+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Geography & Life Sciences: Chapter 54207

Chapter 54207 provides bibliographic information on scholary research in geography and in the life sciences.

MDGs--A public health professional's perspective from 71 countries. Journal of Public Health Policy 34(1): E1-22

MDHAQ/RAPID3 can provide a roadmap or agenda for all rheumatology visits when the entire MDHAQ is completed at all patient visits and reviewed by the doctor before the encounter. Bulletin of the Nyu Hospital for Joint Diseases 70(3): 177-186

MDHAQ/RAPID3 scores: quantitative patient history data in a standardized "scientific" format for optimal assessment of patient status and quality of care in rheumatic diseases. Bulletin of the Nyu Hospital for Joint Diseases 69(3): 201-214

MDHAQ/RAPID3 to recognize improvement over 2 months in usual care of patients with osteoarthritis, systemic lupus erythematosus, spondyloarthropathy, and gout, as well as rheumatoid arthritis. Journal of Clinical Rheumatology 19(4): 169-174

MDHVC researcher co-authors paper on lifestyle changes and diabetes. Methodist Debakey Cardiovascular Journal 9(1): 61-61

MDI inhalers: do nursing home support staff have correct technique?. Journal of Asthma 44(5): 403-405

MDI should be on short list implementation. Medical device integration is a strategic asset for meaningful use and more. Health Management Technology 33(4): 8-9

MDI versus Nebulizers for Acute Asthma. Journal of Pediatric Pharmacology and Therapeutics 9(4): 226-234

MDK investigates significantly more malpractice allegations. The number of confirmed errors has decreased slightly. Pflege Zeitschrift 67(6): 326-327

MDK wants it this way. Pflege Zeitschrift 67(2): 122-123

MDL Information Systems, Inc. Environmental Science & Technology 29(1): 14a-14a

MDL constrained 3-D grayscale skeletonization algorithm for automated extraction of dendrites and spines from fluorescence confocal images. Neuroinformatics 7(4): 213-232

MDL-1, a growth- and tumor-suppressor, slows aging and prevents germline hyperplasia and hypertrophy in C. elegans. Aging 6(2): 98-117

MDL-28170 has no analgesic effect on CCI induced neuropathic pain in mice. Molecules 15(5): 3038-3047

MDLab: a molecular dynamics simulation prototyping environment. Journal of Computational Chemistry 31(7): 1345-1356

MDM Bandpass Filters for the Vacuum Ultraviolet. Applied Optics 7(1): 210-210

MDM-2 antagonists induce p53-dependent cell cycle arrest but not cell death in renal cancer cell lines. Cancer Biology & Therapy 10(12): 1315-1325

MDM2 285G>C and 344T>A gene variants and their association with hepatocellular carcinoma: a Moroccan case-control study. Infectious Agents and Cancer 9(1): 11-11

MDM2 309 T/G polymorphism is associated with colorectal cancer risk especially in Asians: a meta-analysis. Medical Oncology 28(4): 981-985

MDM2 309 T/G polymorphism is associated with lung cancer risk among Asians. European Journal of Cancer 45(11): 2023-2026

MDM2 309 polymorphism is associated with missed abortion. Human Reproduction 24(6): 1346-1349

MDM2 309 polymorphism predicts outcome in platinum-treated locally advanced head and neck cancer. Oral Oncology 48(7): 602-607

MDM2 309T>G polymorphism and risk of squamous cell carcinomas of head and neck: a meta-analysis. Asian Pacific Journal of Cancer Prevention 12(8): 1899-1903

MDM2 Amplification and PI3KCA Mutation in a Case of Sclerosing Rhabdomyosarcoma. Sarcoma 2013: 520858-520858

MDM2 E3 ubiquitin ligase mediates UT-A1 urea transporter ubiquitination and degradation. American Journal of Physiology. Renal Physiology 295(5): F1528-F1534

MDM2 Inhibits Axin-Induced p53 Activation Independently of its E3 Ligase Activity. Plos One 8(6): E67529-E67529

MDM2 SNP 309 human papillomavirus infection in cervical carcinogenesis. Gynecologic Oncology 118(3): 258-261

MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer. International Journal of Cancer 131(11): 2710-2716

MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent. Breast Cancer Research and Treatment 111(3): 497-504

MDM2 SNP309 and TP53 R72P associated with severe and febrile neutropenia in breast cancer patients treated with 5-FU/epirubicin/cyclophosphamide. Breast Cancer Research and Treatment 132(3): 947-953

MDM2 SNP309 and p53 codon 72 genetic polymorphisms and risk of AML: an Egyptian study. Annals of Clinical and Laboratory Science 44(4): 449-454

MDM2 SNP309 and risk of cervical cancer. Tumour Biology 35(7): 6185-6186

MDM2 SNP309 and risk of endometrial cancer. Tumour Biology 35(8): 7285-7286

MDM2 SNP309 associates with accelerated pancreatic adenocarcinoma formation. Pancreas 39(1): 76-80

MDM2 SNP309 contributes to non-small cell lung cancer survival in Chinese. Molecular Carcinogenesis 50(6): 433-438

MDM2 SNP309 contributes to tumor susceptibility: a meta-analysis. Journal of Genetics and Genomics 38(8): 341-350

MDM2 SNP309 does not confer an increased risk to oral squamous cell carcinoma but may modulate the age of disease onset. Oral Oncology 45(6): 496-500

MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastoma. Pediatric Blood & Cancer 53(4): 576-583

MDM2 SNP309 genotype is associated with ferritin and LDH serum levels in children with stage 4 neuroblastoma. Pediatric Blood & Cancer 55(2): 267-272

MDM2 SNP309 is an ethnicity-dependent risk factor for digestive tract cancers. Tumour Biology 35(4): 3431-3438

MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis. Human Cell 24(2): 57-64

MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism. Bmc Cancer 8(): 281-281

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia. Journal of Clinical Oncology 26(14): 2252-2257

MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancer. Oncology Reports 27(3): 673-677

MDM2 SNP309 polymorphism and breast cancer risk: a meta-analysis. Molecular Biology Reports 39(4): 3471-3477

MDM2 SNP309 polymorphism and colorectal cancer risk: a meta-analysis. Dna and Cell Biology 31(3): 355-359

MDM2 SNP309 polymorphism and colorectal cancer risk: appraisal of a recent meta-analysis. Dna and Cell Biology 31(3): 270-271

MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma. Clinical Cancer Research 13(14): 4123-4129

MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis. Journal of Experimental & Clinical Cancer Research 32(): 85-85

MDM2 SNP309 polymorphism is associated with lung cancer risk in women: A meta-analysis using METAGEN. Experimental and Therapeutic Medicine 4(4): 569-576

MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1. Bmc Urology 13(): 5-5

MDM2 SNP309 promoter polymorphism confers risk for hereditary melanoma. Melanoma Research 24(3): 190-197

MDM2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia. European Journal of Haematology 85(3): 251-256

MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis. Plos One 8(2): E56918-E56918

MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects. Leukemia & Lymphoma 53(11): 2245-2252

MDM2 SNP309 variation increases cervical cancer risk among Asians. Tumour Biology 35(6): 5331-5337

MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis. Bmc Cancer 11(): 208-208

MDM2 SNP309T>G polymorphism and hepatocellular carcinoma risk: a meta-analysis. Tumour Biology 35(5): 4147-4151

MDM2 SNP309T>G polymorphism and risk of hepatocellular carcinoma: a case-control analysis in a Moroccan population. Cancer Detection and Prevention 32(5-6): 380-385

MDM2 SNP309T>G polymorphism increases susceptibility to hepatitis B virus-related hepatocellular carcinoma in a northeast Han Chinese population. Liver International 32(7): 1172-1178

MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis. Archives of Medical Research 42(2): 149-155

MDM2 T309G has a synergistic effect with P21 ser31arg single nucleotide polymorphisms on the risk of acute myeloid leukemia. Asian Pacific Journal of Cancer Prevention 13(9): 4315-4320

MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation. Journal of Biological Chemistry 284(21): 13987-14000

MDM2 amplification in malignant peripheral nerve sheath tumors correlates with p53 protein expression. Archives of Pathology & Laboratory Medicine 136(1): 95-99

MDM2 amplification is an independent prognostic feature of node-negative, estrogen receptor-positive early-stage breast cancer. Cancer Biomarkers 8(2): 53-60

MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype. American Journal of Surgical Pathology 36(3): 423-431

MDM2 and CDKN1A gene polymorphisms and risk of Kaposi's sarcoma in African and Caucasian patients. Biomarkers 16(1): 42-50

MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation. Journal of Cell Science 123(Pt 14): 2423-2433

MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02. Journal of Clinical Oncology 27(19): 3177-3184

MDM2 and MDM4 splicing: an integral part of the cancer spliceome. Frontiers in Bioscience 14: 2647-2656

MDM2 and MDMX in cancer and development. Current Topics in Developmental Biology 94: 45-75

MDM2 and MDMX: Alone and together in regulation of p53. Translational Cancer Research 1(2): 88-89

MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Carcinogenesis 29(6): 1192-1196

MDM2 antagonism by nutlin-3 induces death in human medulloblastoma cells. Neuroscience Letters 513(1): 106-110

MDM2 antagonist Nutlin-3 enhances bortezomib-mediated mitochondrial apoptosis in TP53-mutated mantle cell lymphoma. Cancer Letters 299(2): 161-170

MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro. Journal of Gastroenterology and Hepatology 26(2): 371-377

MDM2 antagonist nutlin plus proteasome inhibitor velcade combination displays a synergistic anti-myeloma activity. Cancer Biology & Therapy 9(11): 936-944

MDM2 antagonist nutlin-3 displays antiproliferative and proapoptotic activity in mantle cell lymphoma. Clinical Cancer Research 15(3): 933-942

MDM2 antagonist nutlin-3a reverses mitoxantrone resistance by inhibiting breast cancer resistance protein mediated drug transport. Biochemical Pharmacology 82(1): 24-34

MDM2 antagonists synergize broadly and robustly with compounds targeting fundamental oncogenic signaling pathways. Oncotarget 5(8): 2030-2043

MDM2 as a modifier gene in retinoblastoma. Journal of the National Cancer Institute 102(23): 1805-1808

MDM2 controls the timely expression of cyclin A to regulate the cell cycle. Molecular Cancer Research 7(8): 1253-1267

MDM2 copy numbers in well-differentiated and dedifferentiated liposarcoma: characterizing progression to high-grade tumors. American Journal of Clinical Pathology 141(3): 334-341

MDM2 displays differential activities dependent upon the activation status of NFkappaB. Cancer Biology & Therapy 7(1): 38-44

MDM2 expression and regulation in prostate cancer racial disparity. International Journal of Clinical and Experimental Pathology 2(4): 353-360

MDM2 gene SNP309 T/G and p53 gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European Caucasians. Bmc Cancer 8(): 116-116

MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option?. Virchows Archiv 458(2): 197-203

MDM2 gene amplification in colorectal cancer is associated with disease progression at the primary site, but inversely correlated with distant metastasis. Genes, Chromosomes & Cancer 49(7): 620-629

MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancers. Molecular Cancer Research 6(2): 205-211

MDM2 inhibition in liposarcoma: a step in the right direction. Lancet. Oncology 13(11): 1070-1071

MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 function. European Journal of Cancer 46(6): 1122-1131

MDM2 inhibitors for pancreatic cancer therapy. Mini Reviews in Medicinal Chemistry 10(6): 518-526

MDM2 is a novel E3 ligase for HIV-1 Vif. Retrovirology 6: 1-1

MDM2 is overexpressed and regulated by the eukaryotic translation initiation factor 4E (eIF4E) in human squamous cell carcinoma of esophagus. Annals of Surgical Oncology 18(5): 1469-1477

MDM2 mRNA expression in the p53 pathway may predict the potential of invasion and liver metastasis in colorectal cancer. Diseases of the Colon and Rectum 51(9): 1395-1402

MDM2 mediates nonproteolytic polyubiquitylation of the DEAD-Box RNA helicase DDX24. Molecular and Cellular Biology 34(17): 3321-3340

MDM2 mediates ubiquitination and degradation of activating transcription factor 3. Journal of Biological Chemistry 285(35): 26908-26915

MDM2 molecular imaging for the prediction of chemotherapeutic sensitivity in human breast cancer xenograft. Molecular Imaging 13: -

MDM2 oncogene, E3 ubiquitin protein ligase T309G polymorphism and risk of oesophageal or gastric cancer: meta-analysis of 15 studies. Journal of International Medical Research 42(5): 1065-1076

MDM2 overexpression deregulates the transcriptional control of RB/E2F leading to DNA methyltransferase 3A overexpression in lung cancer. Clinical Cancer Research 18(16): 4325-4333

MDM2 overexpression in benign and malignant lesions of the human breast. International Journal of Oncology 8(5): 895-899

MDM2 overexpression, activation of signaling networks, and cell proliferation. Sub-Cellular Biochemistry 85: 215-234

MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program. Blood 122(15): 2630-2640

MDM2 polymorphism associated with the development of cervical lesions in women infected with Human papillomavirus and using of oral contraceptives. Infectious Agents and Cancer 9(): 24-24

MDM2 polymorphism increases susceptibility to childhood acute myeloid leukemia: a report from the Children's Oncology Group. Pediatric Blood & Cancer 55(2): 248-253

MDM2 polymorphism, survival, and histology in early-stage non-small-cell lung cancer. Journal of Clinical Oncology 25(16): 2243-2247

MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk. Oncotarget 2(3): 251-258

MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL. International Journal of Cancer 130(9): 2054-2061

MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population. Clinical Cancer Research 13(9): 2627-2633

MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk. Plos One 7(4): E36263-E36263

MDM2 promoter polymorphism and pancreatic cancer risk and prognosis. Clinical Cancer Research 14(12): 4010-4015

MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population. Cancer Epidemiology 34(4): 448-452

MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity. Cell Cycle 10(18): 3176-3188

MDM2 promotes cell motility and invasiveness through a RING-finger independent mechanism. Febs Letters 584(22): 4695-4702

MDM2 promotes invasion and metastasis in invasive ductal breast carcinoma by inducing matrix metalloproteinase-9. Plos One 8(11): E78794-E78794

MDM2 promotes proteasomal degradation of p21Waf1 via a conformation change. Journal of Biological Chemistry 285(24): 18407-18414

MDM2 promotes the proteasomal degradation of p73 through the interaction with Itch in HeLa cells. Biochemical and Biophysical Research Communications 403(3-4): 405-411

MDM2 promotor polymorphism and disease characteristics in CLL. Leukemia Research 34(5): 578-579

MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis. Haematologica 99(8): 1285-1291

MDM2 protein-mediated ubiquitination of numb protein: identification of a second physiological substrate of MDM2 that employs a dual-site docking mechanism. Journal of Biological Chemistry 287(17): 14052-14068

MDM2 regulates estrogen receptor α and estrogen responsiveness in breast cancer cells. Journal of Molecular Endocrinology 46(2): 67-79

MDM2 regulates hypoxic hypoxia-inducible factor 1α stability in an E3 ligase, proteasome, and PTEN-phosphatidylinositol 3-kinase-AKT-dependent manner. Journal of Biological Chemistry 289(33): 22785-22797

MDM2 rs2279744 and TP53 rs1042522 polymorphisms associated with etoposide- and cisplatin-induced grade III/IV neutropenia in Chinese extensive-stage small-cell lung cancer patients. Oncology Research and Treatment 37(4): 176-180

MDM2 rs2279744 polymorphism and endometrial cancer: a meta-analysis. Tumour Biology 35(4): 3167-3170

MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models. Cancer Research 73(8): 2587-2597

MDM2, P53, P21WAF1 and pAKT protein levels in genesis and behaviour of adenoid cystic carcinoma. Cancer Epidemiology 33(2): 142-146

MDM2-A, a common Mdm2 splice variant, causes perinatal lethality, reduced longevity and enhanced senescence. Disease Models & Mechanisms 2(1-2): 47-55

MDM2-MOF-H4K16ac axis contributes to tumorigenesis induced by Notch. Febs Journal 281(15): 3315-3324

MDM2-dependent inhibition of p53 is required for Epstein-Barr virus B-cell growth transformation and infected-cell survival. Journal of Virology 83(6): 2491-2499

MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer. Science Signaling 7(336): Ra71-Ra71

MDM2-p53 interaction in paediatric solid tumours: preclinical rationale, biomarkers and resistance. Current Drug Targets 15(1): 114-123

MDM2-p53 protein-protein interaction inhibitors: a-ring substituted isoindolinones. Bioorganic & Medicinal Chemistry Letters 21(19): 5916-5919

MDM2-positive atypical lipomatous neoplasm/well-differentiated liposarcoma versus spindle cell lipoma of the orbit. Ophthalmic Plastic and Reconstructive Surgery 26(6): 413-415

MDM2-related responses in 3T3-L1 adipocytes exposed to cooling and subsequent rewarming. Cryobiology 61(3): 308-316

MDM2/MDMX inhibitor peptide: WO2008106507. Expert Opinion on Therapeutic Patents 19(5): 721-726

MDM2SNP309 does not associate with elevated MDM2 protein expression or breast cancer risk. Oncology 74(1-2): 84-87

MDM4 (MDMX) and its Transcript Variants. Current Genomics 10(1): 42-50

MDM4 (MDMX) is overexpressed in chronic lymphocytic leukaemia (CLL) and marks a subset of p53wild-type CLL with a poor cytotoxic response to Nutlin-3. British Journal of Haematology 150(2): 237-239

MDM4 binds ligands via a mechanism in which disordered regions become structured. Febs Letters 584(14): 3035-3041

MDM4 downregulates p53 transcriptional activity and response to stress during differentiation. Cell Cycle 10(7): 1100-1108

MDM4 enhances p53 stability by promoting an active conformation of the protein upon DNA damage. Cell Cycle 11(4): 749-760

MDM4 overexpressed in acute myeloid leukemia patients with complex karyotype and wild-type TP53. Plos One 9(11): E113088-E113088

MDM4 overexpression contributes to synoviocyte proliferation in patients with rheumatoid arthritis. Biochemical and Biophysical Research Communications 401(3): 417-421

MDMA & cannabis: a mini-review of cognitive, behavioral, and neurobiological effects of co-consumption. Current Drug Abuse Reviews 4(2): 81-86

MDMA 'ecstasy' increases cerebral cortical perfusion determined by bolus-tracking arterial spin labelling (btASL) MRI. British Journal of Pharmacology 169(5): 974-987

MDMA ("ecstasy") abuse as an example of dopamine neuroplasticity. Neuroscience and Biobehavioral Reviews 35(5): 1203-1218

MDMA ("ecstasy") impairs learning in the Morris Water Maze and reduces hippocampal LTP in young rats. Neuroscience Letters 469(3): 375-379

MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology. Current Neuropharmacology 11(5): 521-534

MDMA (3,4-methylendioxymetamphetamine) conference held at the Brain Sciences Institute, Swinburne University, Melbourne, on 11-13th September 2008. Preface. Neuropsychobiology 60(3-4): 117-118

MDMA (3,4-methylenedioxymethamphetamine)-mediated distortion of somatosensory signal transmission and neurotransmitter efflux in the ventral posterior medial thalamus. Journal of Pharmacology and Experimental Therapeutics 327(1): 20-31

MDMA (Ecstasy). Annals of Clinical Psychiatry 19(1): 45-52

MDMA (Ecstasy) decreases the number of neurons and stem cells in embryonic cortical cultures. Cellular and Molecular Neurobiology 30(1): 13-21

MDMA (ecstasy) delays pubertal development and alters sperm quality after developmental exposure in the rat. Toxicology Letters 197(2): 135-142

MDMA (ecstasy) enhances loud noise-induced morphofunctional alterations in heart and adrenal gland. Microscopy Research and Technique 74(9): 874-887

MDMA (ecstasy) modulates locomotor and prefrontal cortex sensory evoked activity. Brain Research 1302: 175-182

MDMA (ecstasy) toxicity: pharmacolinetic, metabolism, cell response and pathological consequences. Current Pharmaceutical Biotechnology 11(5): 411-412

MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study. Journal of Psychopharmacology 24(2): 187-201

MDMA administration and heat shock proteins response: foreseeing a molecular link. Current Pharmaceutical Biotechnology 11(5): 496-499

MDMA administration decreases serotonin but not N-acetylaspartate in the rat brain. Neurotoxicology 31(6): 654-661

MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex. Psychopharmacology 231(20): 4007-4018

MDMA alters emotional processing and facilitates positive social interaction. Psychopharmacology 231(21): 4219-4229

MDMA and 5-HT neurotoxicity: the empirical evidence for its adverse effects in humans - no need for translation. British Journal of Pharmacology 166(5): 1518-20; Discussion 1521-2

MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used 'Ecstasy' during pregnancy. Human Psychopharmacology 29(1): 1-7

MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration. Therapeutic Drug Monitoring 33(5): 602-608

MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study. Psychopharmacology 215(3): 527-536

MDMA and the "ecstasy paradigm". Journal of Psychoactive Drugs 46(1): 44-56

MDMA as a clinical tool: a note of caution. A response to Sessa and Nutt. Journal of Psychopharmacology 22(8): 929-931

MDMA assisted psychotherapy found to have a large effect for chronic post-traumatic stress disorder. Journal of Psychopharmacology 27(9): 865-866

MDMA can increase cortisol levels by 800% in dance clubbers. Journal of Psychopharmacology 27(1): 113-114

MDMA causes a redistribution of serotonin transporter from the cell surface to the intracellular compartment by a mechanism independent of phospho-p38-mitogen activated protein kinase activation. Neuroscience 168(1): 82-95

MDMA decreases the effects of simulated social rejection. Pharmacology, Biochemistry, and Behavior 117: 1-6

MDMA effects consistent across laboratories. Psychopharmacology 231(19): 3899-3905

MDMA enhances emotional empathy and prosocial behavior. Social Cognitive and Affective Neuroscience 9(11): 1645-1652

MDMA enhances hippocampal-dependent learning and memory under restrictive conditions, and modifies hippocampal spine density. Psychopharmacology 231(5): 863-874

MDMA impairs mitochondrial neuronal trafficking in a Tau- and Mitofusin2/Drp1-dependent manner. Archives of Toxicology 88(8): 1561-1572

MDMA induces cardiac contractile dysfunction through autophagy upregulation and lysosome destabilization in rats. Biochimica et Biophysica Acta 1842(5): 691-700

MDMA is certainly damaging after 25 years of empirical research: a reply and refutation of Doblin et al. (2014). Human Psychopharmacology 29(2): 109-119

MDMA modulates spontaneous firing of subthalamic nucleus neurons in vitro. Experimental Brain Research 233(1): 137-147

MDMA pretreatment leads to mild chronic unpredictable stress-induced impairments in spatial learning. Behavioral Neuroscience 123(5): 1076-1084

MDMA reinstates cocaine-seeking behaviour in mice. European Neuropsychopharmacology 19(6): 391-397

MDMA self-administration in laboratory animals: a summary of the literature and proposal for future research. Neuropsychobiology 60(3-4): 130-136

MDMA toxicity and pathological consequences: a review about experimental data and autopsy findings. Current Pharmaceutical Biotechnology 11(5): 500-509

MDMA treatment 6 months earlier attenuates the effects of CP-94,253, a 5-HT1B receptor agonist, on motor control but not sleep inhibition. Brain Research 1231: 34-46

MDMA, cortisol, and heightened stress in recreational ecstasy users. Behavioural Pharmacology 25(5-6): 458-472

MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research. Drug and Alcohol Review 26(1): 9-15

MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant?. Frontiers in Genetics 3: 235-235

MDMA, politics and medical research: have we thrown the baby out with the bathwater?. Journal of Psychopharmacology 21(8): 787-791

MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder. Journal of Psychoactive Drugs 40(3): 225-236

MDMA-evoked changes in the binding of dopamine D(2) receptor ligands in striatum of rats with unilateral serotonin depletion. Synapse 64(1): 70-82

MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635. Brain Research Bulletin 86(1-2): 65-73

MDMA-induced serotonergic neurotoxicity enhances aggressiveness in low- but not high-aggressive rats. European Journal of Pharmacology 618(1-3): 22-27

MDMA: a social drug in a social context. Psychopharmacology 232(6): 1155-1163

MDMA: on the translation from rodent to human dosing. Psychopharmacology 204(2): 375-378

MDMM 2008. Proceedings of the International Conference: Modeling & Design of Molecular Materials, 23-28 June 2008, Piechowice, Poland. Journal of Molecular Modeling 15(6): 565-764

MDMS: Molecular Dynamics Meta-Simulator for evaluating exchange type sampling methods. Chemical Physics Letters 545: 118-124

MDMX contains an autoinhibitory sequence element. Proceedings of the National Academy of Sciences of the United States of America 110(44): 17814-9

MDN-0104, an antiplasmodial betaine lipid from Heterospora chenopodii. Journal of Natural Products 77(9): 2118-2123

MDP bone scan in the early identification of polyarticular aspergillosis. International Journal of Infectious Diseases 17(9): E788-E789

MDP up-regulates the gene expression of type I interferons in human aortic endothelial cells. Molecules 17(4): 3599-3608

MDP uptake in peritoneal carcinomatosis and Krukenberg tumors from mucinous adenocarcinoma. Clinical Nuclear Medicine 36(3): 235-236

MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients. Inflammatory Bowel Diseases 15(11): 1686-1696

MDP-NOD2 stimulation induces HNP-1 secretion, which contributes to NOD2 antibacterial function. Inflammatory Bowel Diseases 16(5): 736-742

MDP-induced interleukin-1beta processing requires Nod2 and CIAS1/NALP3. Journal of Leukocyte Biology 82(1): 177-183

MDPD: an integrated genetic information resource for Parkinson's disease. Nucleic Acids Research 37(Database Issue): D858-D862

MDPHnet: secure, distributed sharing of electronic health record data for public health surveillance, evaluation, and planning. American Journal of Public Health 104(12): 2265-2270

MDPs with Non-Deterministic Policies. Advances in Neural Information Processing Systems 21: 1065-1073

MDR TB transmission, Singapore. Emerging Infectious Diseases 19(7): 1151-1152

MDR gene expression analysis of six drug-resistant ovarian cancer cell lines. Biomed Research International 2013: 241763-241763

MDR quinone oxidoreductases: the human and yeast zeta-crystallins. Chemico-Biological Interactions 178(1-3): 288-294

MDR reversal activity of bromotetrandrine in vitro and in vivo. Zhongguo Shi Yan Xue Ye Xue Za Zhi 17(5): 1183-1191

MDR tuberculosis. Duodecim; Laaketieteellinen Aikakauskirja 130(16): 1599-1605

MDR tuberculosis and non-compliance with therapy. Lancet. Infectious Diseases 12(3): 178; Author Reply 178-9

MDR tuberculosis challenges global health-care targets. Lancet. Respiratory Medicine 1(10): 755-755

MDR tuberculosis--critical steps for prevention and control. New England Journal of Medicine 363(11): 1050-1058

MDR, pre-XDR and XDR drug-resistant tuberculosis in Poland in 2000-2009. Pneumonologia i Alergologia Polska 79(4): 278-287

MDR- and CYP3A4-mediated drug-drug interactions. Journal of Neuroimmune Pharmacology 1(3): 323-339

MDR- and XDR-TB among suspected drug-resistant TB patients in a tertiary care hospital in India. Clinical Respiratory Journal 5(1): 19-25

MDR-/XDR-TB management: what it was, current standards and what is ahead. Expert Review of Respiratory Medicine 3(2): 133-145

MDR-1 and MRP2 Gene Polymorphisms in Mexican Epileptic Pediatric Patients with Complex Partial Seizures. Frontiers in Neurology 5: 184-184

MDR-1 gene C/T polymorphism in COPD: data from Aegean part of Turkey. International Journal of Clinical and Experimental Medicine 7(10): 3573-3577

MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome. Oncology Letters 2(2): 379-381

MDR-1 genotypes and quetiapine pharmacokinetics in healthy volunteers. Drug Metabolism and Drug Interactions 28(3): 163-166

MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. Medical Oncology 28(4): 1549-1554

MDR-ABC transporters: biomarkers in rheumatoid arthritis. Clinical and Experimental Rheumatology 31(5): 779-787

MDR-ER: balancing functions for adjusting the ratio in risk classes and classification errors for imbalanced cases and controls using multifactor-dimensionality reduction. Plos One 8(11): E79387-E79387

MDR-TB and XDR-TB: drug resistance and treatment outcomes. European Respiratory Journal 34(3): 778-779

MDR-TB has new drug foe after fast-track approval. JAMA 309(5): 430-430

MDR-TB in Finland--still rare despite the situation in our neighbouring countries. Clinical Respiratory Journal 6(1): 35-39

MDR-TB in children: need for clear guidelines. International Journal of Tuberculosis and Lung Disease 13(12): 1578-1579

MDR-TB--interventional strategy. Indian Journal of Tuberculosis 54(3): 110-116

MDR-TB--its characteristics and control in Asia-Pacific rim symposium in USJCMSP 10th international conference on emerging infectious diseases in the Pacific rim. Tuberculosis 87 Suppl 1: S5-S9

MDR-selective microbial-based therapy: a novel approach to cancer treatment. Medical Hypotheses 81(2): 207-211

MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents. Cancer ChemoTherapy and Pharmacology 64(1): 183-188

MDR1 (ABCB1) gene encoding glycoprotein P (P-gp), a member of ABC transporter superfamily: consequences for therapy and progression of neoplastic diseases. Postepy Biochemii 53(4): 361-373

MDR1 (ABCB1) polymorphisms: functional effects and clinical implications. Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 65(5): 445-454

MDR1 (multidrug resistence 1) can regulate GCS (glucosylceramide synthase) in breast cancer cells. Journal of Surgical Oncology 104(5): 466-471

MDR1 3435T and 1236T alleles delay disease progression to pediatric AIDS but have no effect on HIV-1 vertical transmission. Aids 24(6): 833-840

MDR1 C2005T polymorphism changes substrate specificity. Cancer ChemoTherapy and Pharmacology 66(3): 617-623

MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case-control studies. Molecular Biology Reports 39(7): 7237-7249

MDR1 C3435T polymorphism and inflammatory bowel disease risk: a meta-analysis. Molecular Biology Reports 41(4): 2679-2685

MDR1 C3435T polymorphism and interaction with environmental factors in risk of Parkinson's disease: a case-control study in Japan. Drug Metabolism and Pharmacokinetics 28(2): 138-143

MDR1 C3435T polymorphism associated with the development of clinical features in Behçet's disease in Iranian Azeri Turkish patients. International Journal of Dermatology 53(10): 1235-1240

MDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in Japanese. Life Sciences 83(7-8): 301-304

MDR1 C3435T polymorphism in Mexican children with acute lymphoblastic leukemia and in healthy individuals. Human Biology 80(4): 449-455

MDR1 C3435T polymorphism in Mexican patients with breast cancer. Genetics and Molecular Research 13(3): 5018-5024

MDR1 C3435T polymorphism in patients with breast cancer. Archives of Medical Research 38(5): 539-544

MDR1 C3435T polymorphism indicates a different outcome in advanced multiple myeloma. Acta Haematologica 122(1): 42-45

MDR1 and CYP3A4 polymorphisms are associated with HIV seropositivity in Israeli patients but do not influence the course of HIV disease. Aids Patient Care and Stds 21(9): 653-658

MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy. Neoplasia 12(8): 628-636

MDR1 and LPL genetic variants are associated with unfavorable outcome in stroke patients under atorvastatin treatment. Pharmacogenomics 14(1): 14-15

MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells. Journal of Huazhong University of Science and Technology. Medical Sciences 27(6): 721-724

MDR1 and OAT1/OAT3 mediate the drug-drug interaction between puerarin and methotrexate. Pharmaceutical Research 31(5): 1120-1132

MDR1 and cytochrome P450 gene-expression profiles as markers of chemosensitivity in human chronic myelogenous leukemia cells treated with cisplatin and Ru(III) metallocomplexes. Biological Trace Element Research 163(1-2): 39-47

MDR1 function is sensitive to the phosphorylation state of myosin regulatory light chain. Biochemical and Biophysical Research Communications 398(1): 7-12

MDR1 gene C3435T polymorphism is associated with clinical outcomes in gastric cancer patients treated with postoperative adjuvant chemotherapy. Asian Pacific Journal of Cancer Prevention 12(9): 2405-2409

MDR1 gene in tardive dyskinesia scale scores: comparison of strategies for quantitative trait haplotype analysis. Schizophrenia Research 110(1-3): 200-201

MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 32(6): 1439-1444

MDR1 gene polymorphisms and P-glycoprotein expression in respiratory diseases. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 159(3): 341-346

MDR1 gene polymorphisms and imatinib response in chronic myeloid leukemia: a meta-analysis. Pharmacogenomics 15(5): 667-677

MDR1 gene polymorphisms and response to acute risperidone treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry 34(2): 387-392

MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation. Journal of Surgical Oncology 96(1): 62-68

MDR1 gene polymorphisms are associated with glucocorticoid-induced avascular necrosis of the femoral head in a Chinese population. Genetic Testing and Molecular Biomarkers 18(3): 196-201

MDR1 gene polymorphisms may be associated with Behçet's disease and its colchicum treatment response. Gene 505(2): 333-339

MDR1 gene polymorphisms: possible association with its expression and clinicopathology characteristics in colorectal cancer patients. Asian Pacific Journal of Cancer Prevention 12(11): 3141-3145

MDR1 haplotypes conferring an increased expression of intestinal CYP3A4 rather than MDR1 in female living-donor liver transplant patients. Pharmaceutical Research 26(7): 1590-1595

MDR1 in paroxetine-induced sexual dysfunction. Journal of Sex & Marital Therapy 39(1): 71-78

MDR1 is related to intestinal epithelial injury induced by acetylsalicylic acid. Cellular Physiology and Biochemistry 32(4): 942-950

MDR1 mRNA expression and MDR1 gene variants as predictors of response to chemotherapy in patients with acute myeloid leukaemia: a meta-analysis. Biomarkers 18(5): 425-435

MDR1 modulates apoptosis in CD34+ leukemic cells. Annals of Hematology 87(12): 1017-1018

MDR1 polymorphism role in patients treated with cetuximab and irinotecan in irinotecan refractory colorectal cancer. Medical Oncology 27(4): 1066-1072

MDR1 polymorphisms associated with risk and survival in diffuse large B-cell lymphoma. Leukemia & Lymphoma 54(6): 1188-1193

MDR1 polymorphisms effect cyclosporine AUC0-4 values in Behçet's disease patients. Clinical Ophthalmology 1(3): 297-303

MDR1 pump: more than a drug transporter comment on "Regulatory polymorphisms of multidrug resistance 1 (MDR1) gene are associated with the development of childhood acute lymphoblastic leukaemia" by Hattori et al. [Leuk. Res. (in press). Leukemia Research 32(2): 359-360

MDR1 single nucleotide polymorphism G2677T/A and haplotype are correlated with response to docetaxel-cisplatin chemotherapy in patients with non-small-cell lung cancer. Respiration; International Review of Thoracic Diseases 78(1): 49-55

MDR1 single nucleotide polymorphisms predict response to vinorelbine-based chemotherapy in patients with non-small cell lung cancer. Respiration; International Review of Thoracic Diseases 75(4): 380-385

MDR1 synonymous polymorphisms alter transporter specificity and protein stability in a stable epithelial monolayer. Cancer Research 74(2): 598-608

MDR1 transporter protects against paraquat-induced toxicity in human and mouse proximal tubule cells. Toxicological Sciences 141(2): 475-483

MDR1 variants and risk of Parkinson disease. Association with pesticide exposure?. Journal of Neurology 256(1): 115-120

MDR1(ABCB1) gene polymorphisms associated with steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus. Die Pharmazie 62(12): 930-932

MDR1, MRP1 and LRP expression in patients with untreated acute leukaemia: correlation with 99mTc-MIBI bone marrow scintigraphy. Nuclear Medicine Communications 28(7): 541-546

MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier. Brain Pathology 17(4): 347-353

MDR1-associated resistance to artesunate+mefloquine does not impair blood-stage parasite fitness in a rodent malaria model. Infection, Genetics and Evolution 14: 340-346

MDR1/ABCB1 polymorphisms and multidrug resistance in epilepsy: in and out of fashion. Pharmacogenomics 10(5): 711-713

MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol. Annals of Surgical Oncology 16(5): 1421-1428

MDR1A (ABCB1)-deficient CF-1 mutant mice are susceptible to cerebral malaria induced by Plasmodium berghei ANKA. Journal of Parasitology 94(5): 1139-1142

MDR1a/1b gene silencing enhances drug sensitivity in rat fibroblast-like synoviocytes. Journal of Gene Medicine 12(2): 219-227

MDR3 immunostaining on frozen liver biopsy samples is not a sensitive diagnostic tool for the detection of heterozygous MDR3/ABCB4 gene mutations. Virchows Archiv 460(5): 535-7; Author Reply 539

MDR3 mutations associated with intrahepatic and gallbladder cholesterol cholelithiasis: an update. Annals of Hepatology 6(3): 143-149

MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant?. Bmc Nephrology 11(): 8-8

MDRD versus CKD-EPI equation to estimate glomerular filtration rate in kidney transplant recipients. Transplantation 95(10): 1211-1217

MDRL lncRNA regulates the processing of miR-484 primary transcript by targeting miR-361. Plos Genetics 10(7): E1004467-E1004467

MDRView: a visualization of the polymorphisms of MDR1(ABCB1) GENE in breast cancer. Conference Proceedings 2007: 4592-4594

MDS 3.0 Section O: an update for certified therapeutic recreation practice with medicare patients. Journal of Gerontological Nursing 36(10): 5-5

MDS 3.0 news from the frontlines. Provider 37(1): 37-39

MDS 3.0 perspective: a better tool for patient care. Journal of the American Medical Directors Association 14(3): 221-222

MDS 3.0 promises positive change. Provider 36(6): 22-3, 25-6, 28 Passim

MDS 3.0 section M: Skin Conditions: what the medical director needs to know. Journal of the American Medical Directors Association 12(3): 179-183

MDS 3.0: a giant step forward, but what about items on resident-to-resident aggression?. Journal of the American Medical Directors Association 14(8): 624-625

MDS 3.0: brief interview for mental status. Journal of the American Medical Directors Association 13(7): 611-617

MDS 3.0: can this release be all things to all people?. Journal of the American Medical Directors Association 13(7): 576-577

MDS 3.0: looking back, looking forward. Provider 39(7): 40-42

MDS 3.0: more training needed. Social workers concerned about interview requirements. Provider 36(10): 85, 87, 89-85, 87, 89

MDS 3.0: setting the stage. Provider 36(8): 33-35

MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation. Blood 114(16): 3448-3458

MDS is a stem cell disorder after all. Cancer Cell 25(6): 713-714

MDS researchers seek treatments but find few. Journal of the National Cancer Institute 99(13): 996-997

MDS with del(5q) and associated cKIT D816V positive mastocytosis. Pathology 44(5): 492-493

MDS-based multiresolution nonlinear dimensionality reduction model for color image segmentation. IEEE Transactions on Neural Networks 22(3): 447-460

MDS-based state Medicaid reimbursement and the ADL-decline quality indicator. Gerontologist 48(3): 324-329

MDS-related mutations in aplastic anemia. Blood 124(17): 2619-2620

MDS-specific comorbidity index is useful to identify myelodysplastic patients who can have better outcome with 5-azacitidine. Haematologica 97(2): E2-E2

MDS: a stem cell disorder--but what exactly is wrong with the primitive hematopoietic cells in this disease?. Hematology. American Society of Hematology. Education Program: 43-51

MDS: roadblock to differentiation. Blood 120(10): 1968-1969

MDS: unraveling the mystery. Blood 120(25): 4906-4908

MDS: valuable clinical data that can help improve medication therapy. Consultant Pharmacist 26(10): 710-714

MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy. International Immunopharmacology 11(7): 856-861

MDSC in autoimmunity. International Immunopharmacology 11(7): 789-793

MDSC: a new player in HIV immunopathogenesis. Aids 26(12): 1567-1569

MDSCs mediate angiogenesis and predispose canine mammary tumor cells for metastasis via IL-28/IL-28RA (IFN-λ) signaling. Plos One 9(7): E103249-E103249

MDSCs: the final frontier of the microenvironment in CLL?. Blood 124(5): 666-668

MDT's five-minute interview. Medical Device Technology 19(3): 6-6

MDTRA: a molecular dynamics trajectory analyzer with a graphical user interface. Journal of Computational Chemistry 34(4): 319-325

MDV-1 VP22: a transporter that can selectively deliver proteins into cells. Archives of Virology 154(7): 1027-1034

MDV3100 for the treatment of prostate cancer. Expert Opinion on Investigational Drugs 21(2): 227-233

MDWeb and MDMoby: an integrated web-based platform for molecular dynamics simulations. Bioinformatics 28(9): 1278-1279

MDWiZ: a platform for the automated translation of molecular dynamics simulations. Journal of Molecular Graphics & Modelling 48: 80-86

MDX-RA Medarex Inc. Idrugs 1(4): 476-479

MDcons: Intermolecular contact maps as a tool to analyze the interface of protein complexes from molecular dynamics trajectories. Bmc Bioinformatics 15 Suppl 5(): S1-S1

MDockPP: A hierarchical approach for protein-protein docking and its application to CAPRI rounds 15-19. Proteins 78(15): 3096-3103

MDpocket: open-source cavity detection and characterization on molecular dynamics trajectories. Bioinformatics 27(23): 3276-3285

MDs Should Promote A 'Healthy Lifestyle'. Canadian Family Physician Medecin de Famille Canadien 28: 1917-1917

MDs and dos moving toward a single accreditation system. Iowa Medicine 103(1): 14-14

MDs to follow conscience on physician-assisted death: CMA annual meeting highlights. Cmaj 186(13): 978-978

MDs with MBAs. Physicians mastering the business side of health care. Hospitals & Health Networks 87(9): 24-24

MDs, DPMs, and NPPs: do you know what was submitted on your Medicare claims?. Advances in Skin & Wound Care 25(7): 301-303

ME/CFS and Blastocystis spp or Dientamoeba fragilis, an in-house comparison. British Journal of General Practice 63(607): 73-74

ME1036, a novel carbapenem, with enhanced activity against clinical isolates causing bacteraemic community-acquired pneumonia. Journal of Antimicrobial ChemoTherapy 64(1): 209-210

ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo. Journal of Hepatology 55(1): 11-18

MEADERS: Medication Errors and Adverse Drug Event Reporting system. AMIA ... Annual Symposium Proceedings. AMIA Symposium: 1167-1167

MEAF6/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma. Cancer Letters 347(1): 75-78

MEALS on wheels; a new and progressive step in the care of the aged. What's New 66(203): 2-6

MEALTRAIN: what do inpatient hospitalized children choose to eat?. Journal of Pediatrics 156(4): 685-686

MEANING of psychosomatic medicine. New England Journal of Medicine 236(2): 83-83

MEART: The Semi-Living Artist. Frontiers in Neurorobotics 1: 5-5

MEASLES (rubeola). Medical Bulletin. United States. Army. Army, 1st 3(1): 5-5

MEASLES, German (rubella). Medical Bulletin. United States. Army. Army, 1st 3(1): 6-6

MEASURE IT, IMPROVE IT: the Safer Patients Initiative and quality improvement in subcutaneous insulin therapy for hospital in-patients. Diabetic Medicine 25(8): 960-967

MEASUREMENT of Protein 53 Diffusion Coefficient in Live HeLa Cells Using Raster Image Correlation Spectroscopy (RICS). Journal of Biomaterials and Nanobiotechnology 1(1): 31-36

MEASURING THE GRASSROOTS: Puzzles of Cultivating the Grassroots from the Top Down. Sociological Quarterly 55(3): 467-492

MEASURING family responsibility. Statistical Bulletin 27(5): 6-8

MEAT SCIENCE AND MUSCLE BIOLOGY SYMPOSIUM--anabolic implants and meat quality. Journal of Animal Science 92(1): 3-9

MEAT SCIENCE AND MUSCLE BIOLOGY SYMPOSIUM--implant and beta agonist impacts on beef palatability. Journal of Animal Science 92(1): 10-20

MEAT SCIENCE AND MUSCLE BIOLOGY SYMPOSIUM--implants, muscle development, and meat quality. Journal of Animal Science 92(1): 1-2

MEAT SCIENCE AND MUSCLE BIOLOGY SYMPOSIUM--mechanism of growth hormone stimulation of skeletal muscle growth in cattle. Journal of Animal Science 92(1): 21-29

MEAT SCIENCE AND MUSCLE BIOLOGY SYMPOSIUM--role of satellite cells in anabolic steroid-induced muscle growth in feedlot steers. Journal of Animal Science 92(1): 30-38

MEAT inspection in England and Wales and in Scotland. Veterinary Record 57: 638-638

MEAT-eating plants. Science Illustrated 1(5): 54-54

MEC-17 deficiency leads to reduced α-tubulin acetylation and impaired migration of cortical neurons. Journal of Neuroscience 32(37): 12673-12683

MECC regional initiative in pediatric palliative care: Middle Eastern course on pain management. Journal of Pediatric Hematology/Oncology 34 Suppl 1: S1-11


MECHANICAL cow. Surgeon's Circular Letter. United States. Army. Far East Command. Medical Section: 6-8

MECHANICAL properties of human bones. Journal of the Franklin Institute 247(6): 597-597

MECHANISMS of edema formation. American Journal of Medicine 1: 313-313

MECKEL'S diverticulum with obstruction. Surgeon's Circular Letter. United States. Army. Far East Command. Medical Section: 22-27

MECP2 Duplication Syndrome. Molecular Syndromology 2(3-5): 128-136

MECP2 coding sequence and 3'UTR variation in 172 unrelated autistic patients. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 144b(4): 475-483

MECP2 duplication in a patient with congenital central hypoventilation. American Journal of Medical Genetics. Part A 152a(6): 1591-1593

MECP2 duplication phenotype in symptomatic females: report of three further cases. Molecular Cytogenetics 7(1): 10-10

MECP2 duplication: possible cause of severe phenotype in females. American Journal of Medical Genetics. Part A 164a(4): 1029-1034

MECP2 gene study in a large cohort: testing of 240 female patients and 861 healthy controls (519 females and 342 males). Journal of Molecular Diagnostics 15(5): 723-729

MECP2 genomic structure and function: insights from ENCODE. Nucleic Acids Research 36(19): 6035-6047

MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy. Plos One 4(8): E6810-E6810

MECP2 mutation in one of Rett's original patients. Journal of Medical Genetics 46(9): 647-648

MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders. Brain & Development 34(6): 487-495

MECP2 mutations in Malaysian Rett syndrome patients. Singapore Medical Journal 50(5): 529-533

MECP2 promoter methylation and X chromosome inactivation in autism. Autism Research 1(3): 169-178

MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells. Cellular and Molecular Biology Suppl 59: Ol1876-81

MECs use bacteria on the anode, and either chemical catalysts or bacteria on the cathode. Preface. Bioresource Technology 102(1): 1-1

MED NORD--A tool for measuring medical students' well-being and study orientations. Medical Teacher 30(1): 72-79

MED and PSACH COMP mutations affect chondrogenesis in chicken limb bud micromass cultures. Journal of Cellular Physiology 224(3): 817-826

MED-3DMC: a new tool to generate 3D conformation ensembles of small molecules with a Monte Carlo sampling of the conformational space. European Journal of Medicinal Chemistry 44(4): 1405-1409

MED-SuMoLig: a new ligand-based screening tool for efficient scaffold hopping. Journal of Chemical Information and Modeling 47(3): 1097-1110

MED12 alterations in both human benign and malignant uterine soft tissue tumors. Plos One 7(6): E40015-E40015

MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling. Cell 151(5): 937-950

MED12 exon 2 mutations are common in uterine leiomyomas from South African patients. Oncotarget 2(12): 966-969

MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors. Human Pathology 45(1): 65-70

MED12 mutation frequency in unselected sporadic uterine leiomyomas. Fertility and Sterility 102(4): 1137-1142

MED12 mutations link intellectual disability syndromes with dysregulated GLI3-dependent Sonic Hedgehog signaling. Proceedings of the National Academy of Sciences of the United States of America 109(48): 19763-8

MED12 overexpression is a frequent event in castration-resistant prostate cancer. Endocrine-Related Cancer 21(4): 663-675

MED12 related disorders. American Journal of Medical Genetics. Part A 161a(11): 2734-2740

MED13-dependent signaling from the heart confers leanness by enhancing metabolism in adipose tissue and liver. Embo Molecular Medicine 6(12): 1610-1621

MED14 tethers mediator to the N-terminal domain of peroxisome proliferator-activated receptor gamma and is required for full transcriptional activity and adipogenesis. Molecular and Cellular Biology 30(9): 2155-2169

MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer. International Journal of Cancer 135(1): 19-26

MED19 and MED26 are synergistic functional targets of the RE1 silencing transcription factor in epigenetic silencing of neuronal gene expression. Journal of Biological Chemistry 284(5): 2648-2656

MED19 promotes proliferation and tumorigenesis of lung cancer. Molecular and Cellular Biochemistry 355(1-2): 27-33

MED23 mutation links intellectual disability to dysregulation of immediate early gene expression. Science 333(6046): 1161-1163

MED25 is a mediator component of HNF4α-driven transcription leading to insulin secretion in pancreatic beta-cells. Plos One 7(8): E44007-E44007

MED29, a component of the mediator complex, possesses both oncogenic and tumor suppressive characteristics in pancreatic cancer. International Journal of Cancer 129(11): 2553-2565

MEDAFI-Trial (Micro-embolization during ablation of atrial fibrillation): comparison of pulmonary vein isolation using cryoballoon technique vs. radiofrequency energy. Europace 13(1): 37-44

MEDAL: measuring of emergency departments' adaptive load. Studies in Health Technology and Informatics 160(Pt 1): 218-222

MEDCAPS--do they work?. Journal of the Royal Army Medical Corps 155(3): 182-183

MEDCHI, the Maryland State Medical Society 2011 legislative and regulatory agenda. Maryland Medicine 12(1): 27-27

MEDDB: a medicinal plant database developed with the information gathered from tribal people in and around Madurai, Tamil Nadu. Bioinformation 8(8): 391-393

MEDECOR--a medical decorporation tool to assist first responders, receivers, and medical reach-back personnel in triage, treatment, and risk assessment after internalization of radionuclides. Health Physics 99(4): 581-590

MEDELLER: homology-based coordinate generation for membrane proteins. Bioinformatics 26(22): 2833-2840

MEDEVAC Use of Ketamine for Postintubation Transport. Journal of Special Operations Medicine 13(3): 36-41

MEDEVAC miscategorization. Military Medicine 175(9): 655-658

MEDEVAC: critical care transport from the battlefield. AACN Advanced Critical Care 21(3): 288-297

MEDEVAC: survival and physiological parameters improved with higher level of flight medic training. Military Medicine 178(5): 529-536

MEDEX Program. California Medicine 112(4): 85-85

MEDI-528, an anti-IL-9 humanized antibody for the treatment of asthma. Current Opinion in Molecular Therapeutics 12(2): 233-239

MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function. Journal of Allergy and Clinical Immunology 125(6): 1344-1353.E2

MEDI-573, alone or in combination with mammalian target of rapamycin inhibitors, targets the insulin-like growth factor pathway in sarcomas. Molecular Cancer Therapeutics 13(11): 2662-2673

MEDI0639: a novel therapeutic antibody targeting Dll4 modulates endothelial cell function and angiogenesis in vivo. Molecular Cancer Therapeutics 11(8): 1650-1660

MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models. International Journal of Oncology 40(5): 1321-1330

MEDIC: a practical disease vocabulary used at the Comparative Toxicogenomics Database. Database 2012: Bar065-Bar065

MEDIC: medical embedded device for individualized care. Artificial Intelligence in Medicine 42(2): 137-152

MEDICAL ASPECTS OF THE FOOD PROBLEM: Abstract of a Paper read before the West London Medico-Chirurgical Society on April 5th. British Medical Journal 1(2989): 426-427

MEDICAL Board of Review reports to U.S.A.E.C. Bulletin of the Atomic Scientists 3(9): 272-274

MEDICAL CLINICS PLAN: PUBLIC HEALTH EXHIBITS: Golden Gate International Exposition: San Francisco. California and Western Medicine 48(1): 65-66

MEDICAL COUNCIL OF CANADA: First Announcement, July 1st, 1913. Canadian Medical Association Journal 3(9): 806-809

MEDICAL Council of India. Journal of the Indian Medical Association 15(11): 395-398

MEDICAL DEFENCE UNION: Twenty-first Anniversary. British Medical Journal 1(2369): 1258-1258

MEDICAL Department of the Air Force. Surgeon's Circular Letter. United States. Army. Far East Command. Medical Section 4(7): 5-5

MEDICAL Department officer shortage, fiscal year, 1950. Health of the Army. United States. Surgeon-General's Office 4(6): 2-4

MEDICAL ECONOMICS: COST OF MEDICAL CARE: Outline of Studies: PART III: Analysis of Specially Organized Facilities for Medical Care Now Serving Particular Groups of the Population. California and Western Medicine 29(3): 213-214

MEDICAL ECONOMICS: OUTLINE OF STUDIES: PART I: Preliminary Survey of Data Showing the Incidence of Diseases and Disabilities Requiring Medical Services and of Generally Existing Facilities for Dealing With Them. California and Western Medicine 29(1): 69-70

MEDICAL ECONOMICS: OUTLINE OF STUDIES: PART II: Studies on the Cost to the Family of Medical Services and the Return Accruing to the Physician and Other Agents Furnishing Such Services. California and Western Medicine 29(2): 142-144

MEDICAL ECONOMICS: The Physician's Income Tax-1929. California and Western Medicine 32(1): 67-68

MEDICAL ECONOMICS: Why not let our advertisers help you?. California State Journal of Medicine 21(2): 96-96

MEDICAL EDUCATION AND THE UNIVERSITIES: A Memorandum on Medical Education submitted to the Royal Commission on University Education in London. British Medical Journal 2(2656): 1421-1424

MEDICAL EDUCATION IN ENGLAND: A Note on Sir George Newman's Memorandum to the President of the Board of Education. British Medical Journal 2(3005): 113-115

MEDICAL EDUCATION IN ENGLAND: The Overloaded Curriculum and the Incubus of the Examination System. British Medical Journal 2(3010): 258-259

MEDICAL EDUCATION, PAST AND PRESENT: Sir Glifford Allbutt's Inaugural Address at St. George's. British Medical Journal 2(3223): 655-658

MEDICAL INSPECTION AND AFTER. LONDON: Medical Treatment of School Children. British Medical Journal 1(2519): 914-914

MEDICAL INSPECTION OF SCHOOL CHILDREN: Deputation to Mr. Birrell. British Medical Journal 2(2377): 151-152

MEDICAL JURISPRUDENCE: Malpractice: Sufficiency of Evidence. California and Western Medicine 61(1): 46-46

MEDICAL LEGISLATION: Senate Roll Call on S. B. 175 (Fellom): Which Bill Would Have Given Corporations the Right to Practice Medicine for Profit. California and Western Medicine 35(3): 236-237

MEDICAL LICENSURE statistics for 1946. Journal of the American Medical Association 134(3): 255-290

MEDICAL MEMBERS OF PARLIAMENT: Dinner given by the Medical Parliamentary Committee. British Medical Journal 1(3034): 220-220

MEDICAL OFFICER AND CLERICAL CRITIC: An Apology from the Clergyman. British Medical Journal 2(2223): 330-330

MEDICAL ORGANIZATIONS AND CONSERVATION OF THE PUBLIC HEALTH: President's Address at the Annual Meeting of the Los Angeles County Medical Association, December 15th, 1911. California State Journal of Medicine 10(2): 54-57

MEDICAL PROGRESS: Current Methods for Study and Treatment of Sterility. California Medicine 65(2): 76-80

MEDICAL PROGRESS: The Rh Factor in Clinical Obstetrics. California Medicine 65(3): 125-130

MEDICAL RECORDS: more than mere relevance may be necessary for disclosure of medical records. Alcon v. Spicer. Journal of Healthcare Risk Management 25(3): 38-39

MEDICAL RESEARCH: Beit Memorial Fellowships for Medical Research. British Medical Journal 2(2555): 1762-1763

MEDICAL SOCIETY OF LONDON: 150th ANNIVERSARY DINNER. British Medical Journal 1(3255): 873-874

MEDICAL School, University of Southern California. Bulletin - Los Angeles County Medical Association 76(3): 101-107

MEDICAL Society of New Jersey, 184th Annual Meeting, Atlantic City, New Jersey, May 22-24, 1950. Journal of the Medical Society of New Jersey 47(8): 1-56

MEDICAL Society of the State of North Carolina, officers, committees and roster of fellows. Officers, Committees, and Roster of Fellows. Medical Society of the State of North Carolina 11(8): 1-80

MEDICAL TEACHING IN CANADA IN 1824 AND 1834: IV.-From Colonial Advocate, Aug. 19, 1824, Advertisement. Canadian Medical Association Journal 17(3): 360-361

MEDICAL TERMS IN THE VERNACULAR AND IN DIALECTS: I. Agnails or Hangnails. British Medical Journal 1(3185): 66-67

MEDICAL TERMS IN THE VERNACULAR AND IN DIALECTS: II. Andicomb, Ancome, Uncome, or Income. British Medical Journal 1(3203): 814-815

MEDICAL TERMS IN THE VERNACULAR AND THE DIALECTS: III. Smittle and Smit. British Medical Journal 1(3207): 970-971

MEDICAL administrator and the Service. Practitioner 163(Suppl. to No. 975): 61-68

MEDICAL and sanitary data on Italy. War Department Technical Bulletin. Tb Med: 1-75

MEDICAL books in Spanish. Science News Letter 54(8): 117-117

MEDICAL care charges effective 1 July, 1949. Surgeon's Circular Letter. United States. Army. Far East Command. Medical Section 4(7): 10-10

MEDICAL care for veterans. Journal - Michigan State Medical Society 45: 481-481

MEDICAL curriculum. Nature 160(4067): 481-481

MEDICAL education in Germany. Manchester University Medical School Gazette 28(4): 148-150

MEDICAL education in Glasgow. Glasgow Medical Journal 27: 237-237

MEDICAL education in Queensland. Lancet 2(6416): 248-248

MEDICAL education in South Carolina. Journal of the South Carolina Medical Association 42: 53-61

MEDICAL education in time of national emergency: a statement by the Joint Committee on Medical Education in Time of National Emergency, representing the Association of American Medical Colleges and the Council on Medical Education and Hospitals of the American Medical Association, November 1, 1950. Journal. Association of American Medical Colleges 25(6 Pt 2): 3-14

MEDICAL effects of atomic explosion. Medical Bulletin. United States. Army. European Command. Medical Division 5(2): 28-35

MEDICAL evidence in pension claims. British Medical Journal 1: 745-745

MEDICAL libraries in hospitals. Lancet 2(6575): 430-430

MEDICAL licensure statistics for 1945. Journal of the American Medical Association 131: 109-139

MEDICAL management of uncomplicated peptic ulcer. Roche Review 11(1): 1-17

MEDICAL photography, then and now. Medical Radiography and Photography 23(2): 59-59

MEDICAL poets. British Medical Journal 2: 698-698

MEDICAL practice acts; revocation of doctor's license for commission of an abortion [California. Journal of the American Medical Association 133(5): 346-346

MEDICAL practice acts; revocation of license for abortion; necessity of proving pregnancy [California, 1943. Journal of the American Medical Association 132(16): 1036-1036

MEDICAL preparation of troops for redeployment through the Assembly Area Command. Medical Bulletin. United States. Army. Forces in the European Theater. Office of the Theater Chief Surgeon: 7-7

MEDICAL professional journals. Surgeon's Circular Letter. United States. Army. Far East Command. Medical Section 3(3): 4-9

MEDICAL research in Africa. Lancet 2(6529): 624-626

MEDICAL research in malaria, 1947. Journal. National Malaria Society 7(2): 148-156

MEDICAL research in malariology in the first postwar year, 1945-1946. Journal. National Malaria Society 6(3): 206-216

MEDICAL school and commencement. Journal of the Oklahoma State Medical Association 39(11): 456-456

MEDICAL science and physical education in industry. British Journal of Industrial Medicine 3: 27-39

MEDICAL section of the Library Association; suggestions regarding the proposed new index to medical literature. Bulletin of the Medical Library Association 37(2): 98-103

MEDICAL service in Australia. Lancet 1(6404): 791-791

MEDICAL service plan of the Medical Service Association of Pennsylvania. Pennsylvania Medical Journal 49: 34-36

MEDICAL services in West Africa. Hospital and Health Management 10(122): 499-501

MEDICAL services of Norway. Lancet 1(6385): 67-67

MEDICAL social service in tuberculosis control. Public Health Reports 62(10): 327-336

MEDICAL survey of the bituminous-coal industry. Journal of the American Medical Association 134(6): 537-541

MEDICAL treatment of school children. Medical Officer 75: 195-195

MEDICAL-SURGICAL plan; a report to the profession. Journal of the Medical Society of New Jersey 44(1): 20-23

MEDICINAL AND DIETETIC PREPARATIONS: Organic Arsenic Compounds. British Medical Journal 1(2510): 344-344

MEDICINAL AND DIETETIC PREPARATIONS: Sulphuretted Hydrogen Soloids. British Medical Journal 2(3287): 1268-1268

MEDICINE AND DENTISTRY: First University Dental School in New York for Columbia. California State Journal of Medicine 14(7): 304-304

MEDICINE AND THE PRESENT EMERGENCY: A Manifesto on Moral Re-Armament. Canadian Medical Association Journal 41(4): 391-391

MEDICINE AT THE END OF THE EIGHTEENTH CENTURY: Presidential Address to the Medical Society of London. British Medical Journal 2(3120): 598-598

MEDICINE IN THE SCHOOLS : The Medical Staff. British Medical Journal 2(3126): 826-827

MEDICINE IN THE "ENCYCLOPAEDIA BRITANNICA." : Fifth Notice. British Medical Journal 1(2622): 766-766

MEDICINE and public health. Annual Report. United States National Museum 63: 57-57

MEDICINE and the atomic bomb; radiation sickness found in Nagasaki victims. South African Nursing Journal. Suid-Afrikaanse Verplegingstydskrif 13(1): 19-19

MEDICINE and the changing order. Journal of the American Medical Association 130: 94-94

MEDICINE behind the iron curtain; the experiences of a Russian-speaking German medical officer as a P. O. W. in Russia, 1945-1948. Medical World 70(25): 834-838

MEDICINE faces a crisis; socialisation plans in Great Britian and Australia. Australasian Journal of Pharmacy 27(317): 368-368

MEDICINE from the earth. Australasian Journal of Pharmacy 27(324): 1089-1089

MEDICINE in Germany. Lancet 1(6385): 62-62

MEDICINE in industry. Hospital and Health Management 9: 156-156

MEDICINE in the stone age. Phi Lambda Kappa Quarterly 22(1): 4-7

MEDICO-LEGAL PROBLEMS IN RELATION TO VENEREAL DISEASE: Discussion after Addresses by DR. CROOKSHANK and MR. EWART WORT. British Journal of Venereal Diseases 2(5): 55-58

MEDICO-LEGAL: PLEA FOR REDUCTION OF FEDERAL TAX ON EARNED INCOMES OF PHYSICIANS: Form of Petition to Congress. California and Western Medicine 30(5): 372-373

MEDICOLEGAL * Malpractice and ethical issues in radiology: ACR practice guidelines and standard of care. Ajr. American Journal of Roentgenology 200(3): W324-W324

MEDICOLEGAL: Malpractice and ethical issues in radiology: Limiting requests for outside radiographic interpretations. Ajr. American Journal of Roentgenology 200(1): W92-W92

MEDICOLEGAL: Malpractice and ethical issues in radiology: The incidentaloma. Ajr. American Journal of Roentgenology 200(1): W91-W91

MEDICOLEGAL: Malpractice and ethical issues in radiology: reinterpreting outside mammograms prior to breast biopsy. Ajr. American Journal of Roentgenology 200(3): W325-W325

MEDIFRAME--remote volume rendering visualization framework. Conference Proceedings 2011: 2368-2371

MEDIN implant of the first metatarsophalangeal joint. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 79(2): 124-130

MEDIPS: genome-wide differential coverage analysis of sequencing data derived from DNA enrichment experiments. Bioinformatics 30(2): 284-286

MEDLARS magic. Canadian Medical Association Journal 104(2): 111-113

MEDLINE - International recognition of the development of Brazilian Orthodontic science. Dental Press Journal of Orthodontics 18(4): 1-1

MEDLINE and the European Journal of Orthopaedic Surgery and Traumatology. European Journal of Orthopaedic Surgery & Traumatology 23(3): 249-250

MEDLINE clinical queries are robust when searching in recent publishing years. Journal of the American Medical Informatics Association 20(2): 363-368

MEDLINE indexing and trying to understand the ethical constraints inherent in publishing people's stories: two milestones in the medical humanities journey. Medical Humanities 36(2): 65-66

MEDLINE is only the first step. Revista de Calidad Asistencial 24(4): 137-138

MEDLINE listing and impact factor. Zeitschrift für Orthopadie und Unfallchirurgie 145(6): 679-679

MEDLINE research. How to formulate a request about prognosis?. La Revue du Praticien 60(1): 80-80

MEDLINE research. Interpreting query topics. La Revue du Praticien 60(8): 1116-1116

MEDLINE research. What are the Medline display setting used for?. La Revue du Praticien 61(6): 838-838

MEDLINE versus EMBASE and CINAHL for telemedicine searches. Telemedicine Journal and E-Health 16(8): 916-919

MEDLINE, EMBASE, and Cochrane index most primary studies but not abstracts included in orthopedic meta-analyses. Journal of Clinical Epidemiology 62(12): 1261-1267

MEDLINE-based assessment of animal studies on Chinese herbal medicine. Journal of Ethnopharmacology 140(3): 545-549

MEDME: an experimental and analytical methodology for the estimation of DNA methylation levels based on microarray derived MeDIP-enrichment. Genome Research 18(10): 1652-1659

MEDOR, a didactic tool to support interpretation of bioassay data after internal contamination by actinides. Radiation Protection Dosimetry 127(1-4): 350-355

MEDPILOT: integrated effective medical searches. European Journal of Physical and Rehabilitation Medicine 47(1): 181-184

MEDRank: using graph-based concept ranking to index biomedical texts. International Journal of Medical Informatics 80(6): 431-441

MEDULLARY nailing of fractures. United States Naval Medical Bulletin 49(1): 172-175

MEDWISE: an innovative public health information system infrastructure. Journal of Medical Systems 36(3): 1719-1729

MEEGID VIII Bangkok, Thailand. Infection, Genetics and Evolution 8(4): 395-396

MEET: motif elements estimation toolkit. Conference Proceedings 2011: 6483-6486

MEETING BRIEFS: Hubble Spectrograph Takes a Hard Look in the Ultraviolet. Science 273(5283): 1799-1800

MEETING OF THE BRITISH MEDICAL ASSOCIATION, MANCHESTER, JULY 24 and 25, 1929. British Journal of Ophthalmology 13(9): 456-459

MEETING of Historical Advisory Board. Bulletin of the U.S. Army Medical Department. United States. Army. Medical Department 6: 28-30

MEETING{middle dot} 26-30 DECEMBER. Science 142(3596): 1195-1195

MEETS A.C.S Story of ACS Committee on Analytical Reagents. Analytical Chemistry 42(3): 30a-38a

MEF-2 regulates activity-dependent spine loss in striatopallidal medium spiny neurons. Molecular and Cellular Neurosciences 44(1): 94-108

MEF/ELF4 transactivation by E2F1 is inhibited by p53. Nucleic Acids Research 39(1): 76-88

MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformation. Molecular and Cellular Biology 33(22): 4473-4491

MEF2 is an in vivo immune-metabolic switch. Cell 155(2): 435-447

MEF2 is regulated by CaMKIIδ2 and a HDAC4-HDAC5 heterodimer in vascular smooth muscle cells. Biochemical Journal 444(1): 105-114

MEF2 is restricted to the male gonad and regulates expression of the orphan nuclear receptor NR4A1. Molecular Endocrinology 28(6): 886-898

MEF2 transcription factors promotes EMT and invasiveness of hepatocellular carcinoma through TGF-β1 autoregulation circuitry. Tumour Biology 35(11): 10943-10951

MEF2 transcription factors regulate distinct gene programs in mammalian skeletal muscle differentiation. Journal of Biological Chemistry 290(2): 1256-1268

MEF2 transcriptional activity maintains mitochondrial adaptation in cardiac pressure overload. European Journal of Heart Failure 12(1): 4-12

MEF2A binding to the Glut4 promoter occurs via an AMPKα2-dependent mechanism. Medicine and Science in Sports and Exercise 43(8): 1441-1450

MEF2A gene mutations and susceptibility to coronary artery disease in the Chinese population. Genetics and Molecular Research 13(4): 8396-8402

MEF2A regulates the Gtl2-Dio3 microRNA mega-cluster to modulate WNT signaling in skeletal muscle regeneration. Development 140(1): 31-42

MEF2A sequence variants in Turkish population. Clinical and Applied Thrombosis/Hemostasis 14(4): 465-467

MEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathy. American Journal of Pathology 180(6): 2548-2560

MEF2C enhances dopaminergic neuron differentiation of human embryonic stem cells in a parkinsonian rat model. Plos One 6(8): E24027-E24027

MEF2C exon α: role in gene activation and differentiation. Gene 531(2): 355-362

MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations. Journal of Medical Genetics 47(1): 22-29

MEF2C mutations are a rare cause of Rett or severe Rett-like encephalopathies. Clinical Genetics 82(5): 499-501

MEF2C silencing attenuates load-induced left ventricular hypertrophy by modulating mTOR/S6K pathway in mice. Plos One 4(12): E8472-E8472

MEFS - MIND electrical impedance tomography forward solver. Conference Proceedings 2010: 3105-3108

MEFV E148Q polymorphism is associated with Henoch-Schönlein purpura in Chinese children. Pediatric Nephrology 25(10): 2077-2082

MEFV Variants in Patients with PFAPA Syndrome in Japan. Open Rheumatology Journal 7(): 22-25

MEFV gene 3'-UTR Alu repeat polymorphisms in patients with familial Mediterranean fever. Clinical and Experimental Rheumatology 26(4 Suppl 50): S72-S76

MEFV gene compound heterozygous mutations in familial Mediterranean fever phenotype: a retrospective clinical and molecular study. Nephrology, Dialysis, Transplantation 25(8): 2520-2523

MEFV gene mutation spectrum in familial Mediterranean fever (FMF) : a single center study in the Aegean region of Turkey. Zeitschrift für Rheumatologie 70(6): 511-516

MEFV gene mutations (M694V, V726A, M680I, and A744S) in Iranian children with Henoch-Schönlein purpura. Pneumologia 61(2): 84-87

MEFV gene mutations and cardiac phenotype in children with familial Mediterranean fever: a cohort study. Pediatric Rheumatology Online Journal 12(): 5-5

MEFV gene mutations and its impact on the clinical course in ulcerative colitis patients. Rheumatology International 31(7): 859-864

MEFV gene mutations and their clinical significance in Korean patients with adult-onset Still's disease. Clinical and Experimental Rheumatology 31(3 Suppl 77): 60-63

MEFV gene mutations in Egyptian children with Henoch-Schonlein purpura. Pediatric Rheumatology Online Journal 12(): 41-41

MEFV gene mutations in Egyptian patients with familial Mediterranean fever. Genetic Testing and Molecular Biomarkers 14(2): 263-268

MEFV gene mutations in Henoch-Schönlein purpura. International Journal of Rheumatic Diseases 16(3): 347-351

MEFV gene mutations in a patient with eosinophilic gastroenteritis. Southern Medical Journal 103(11): 1170-1172

MEFV gene mutations spectrum among Lebanese patients referred for Familial Mediterranean Fever work-up: experience of a major tertiary care center. Molecular Biology Reports 35(3): 447-451

MEFV gene polymorphisms and TNFRSF1A mutation in patients with inflammatory myopathy with abundant macrophages. Clinical and Experimental Immunology 178(2): 224-228

MEFV gene variations in patients with systemic lupus erythematosus. Modern Rheumatology 24(1): 93-96

MEFV heterogeneity in Turkish Familial Mediterranean Fever patients. Molecular Biology Reports 37(1): 355-358

MEFV mutation analysis of familial Mediterranean fever in Japan. Clinical and Experimental Rheumatology 26(1): 13-17

MEFV mutations affecting pyrin amino acid 577 cause autosomal dominant autoinflammatory disease. Annals of the Rheumatic Diseases 73(2): 455-461

MEFV mutations and palindromic rheumatism: comment on the article by Cañete et al. Arthritis and Rheumatism 58(6): 1885; Author Reply 1885-6

MEFV mutations in Egyptian children with systemic-onset juvenile idiopathic arthritis. Molecular Diagnosis & Therapy 18(5): 549-557

MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations. Rheumatology International 30(10): 1293-1298

MEFV mutations in Iranian Azeri Turkish patients with familial Mediterranean fever. Clinical Genetics 76(5): 477-480

MEFV mutations in Japanese rheumatoid arthritis patients. Clinical and Experimental Rheumatology 26(6): 1091-1094

MEFV mutations in Moroccan patients suffering from familial Mediterranean Fever. Rheumatology International 32(4): 981-984

MEFV mutations in patients with Familial Mediterranean Fever from the Aegean region of Turkey. Molecular Biology Reports 37(1): 93-98

MEFV mutations in patients with familial Mediterranean fever in the Black Sea region of Turkey: Samsun experience [corrected. Journal of Rheumatology 35(1): 106-113

MEFV mutations in systemic onset juvenile idiopathic arthritis. Rheumatology 48(1): 23-25

MEFV mutations modify the clinical presentation of Henoch-Schönlein purpura. Journal of Rheumatology 35(12): 2427-2429

MEFV, TNF1rA, CARD15 and NLRP3 mutation analysis in PFAPA. Rheumatology International 30(5): 633-636

MEFV, TNFRSF1A and CARD15 mutation analysis in Behçet's disease. Clinical and Experimental Rheumatology 29(4 Suppl 67): S24-S27

MEG analysis in Alzheimer's disease computing approximate entropy for different frequency bands. Conference Proceedings 2010: 2379-2382

MEG and EEG data analysis with MNE-Python. Frontiers in Neuroscience 7: 267-267

MEG and EEG data fusion: simultaneous localisation of face-evoked responses. Neuroimage 47(2): 581-589

MEG and EEG sensitivity in a case of medial occipital epilepsy. Brain Topography 27(1): 192-196

MEG and fMRI Fusion for Non-Linear Estimation of Neural and BOLD Signal Changes. Frontiers in Neuroinformatics 4: 114-114

MEG auditory evoked fields suggest altered structural/functional asymmetry in primary but not secondary auditory cortex in bipolar disorder. Bipolar Disorders 11(4): 371-381

MEG based classification of wrist movement. Conference Proceedings 2009: 986-989

MEG beamforming using Bayesian PCA for adaptive data covariance matrix regularization. Neuroimage 57(4): 1466-1479

MEG brain activities reflecting affection for visual food stimuli. Conference Proceedings 2010: 6575-6578

MEG can map short and long-term changes in brain activity following deep brain stimulation for chronic pain. Plos One 7(6): E37993-E37993

MEG connectivity analysis in patients with Alzheimer's disease using cross mutual information and spectral coherence. Annals of Biomedical Engineering 39(1): 524-536

MEG correlates of bimodal encoding of faces and persons' names. Brain Research 1230: 192-201

MEG correlates of epileptic high gamma oscillations in invasive EEG. Epilepsia 51(8): 1638-1642

MEG correlates of learning novel objects properties in children. Plos One 8(7): E69696-E69696

MEG delta mapping along the healthy aging-Alzheimer's disease continuum: diagnostic implications. Journal of Alzheimer's Disease 35(3): 495-507

MEG demonstrates a supra-additive response to facial and vocal emotion in the right superior temporal sulcus. Proceedings of the National Academy of Sciences of the United States of America 106(47): 20010-5

MEG detection of delayed auditory evoked responses in autism spectrum disorders: towards an imaging biomarker for autism. Autism Research 3(1): 8-18

MEG does not reveal impaired sensory gating in first-episode schizophrenia. Schizophrenia Research 121(1-3): 131-138

MEG dual scanning: a procedure to study real-time auditory interaction between two persons. Frontiers in Human Neuroscience 6: 83-83

MEG evaluation of Parkinson's diseased patients after external magnetic stimulation. Acta Neurologica Belgica 107(1): 5-10

MEG evaluation of taste by gender difference. Journal of Integrative Neuroscience 10(4): 537-545

MEG event-related desynchronization and synchronization deficits during basic somatosensory processing in individuals with ADHD. Behavioral and Brain Functions 4(): 8-8

MEG evidence for conceptual combination but not numeral quantification in the left anterior temporal lobe during language production. Frontiers in Psychology 5: 524-524

MEG evidence for dynamic amygdala modulations by gaze and facial emotions. Plos One 8(9): E74145-E74145

MEG evidence that the LIFG effect of object extraction requires similarity-based interference. Language and Cognitive Processes 29(3): 381-389

MEG evidence that the central auditory system simultaneously encodes multiple temporal cues. European Journal of Neuroscience 30(6): 1183-1191

MEG evoked responses and rhythmic activity provide spatiotemporally complementary measures of neural activity in language production. Neuroimage 60(1): 29-36

MEG in paediatrics: introduction to the special issue. International Journal of Psychophysiology 68(2): 83-84

MEG in the macaque monkey and human: distinguishing cortical fields in space and time. Brain Research 1345: 110-124

MEG localization of spike sources in human patients with brain tumors. Journal of Integrative Neuroscience 13(3): 519-528

MEG mapping in multiple sclerosis patients. Europa Medicophysica 43(3): 345-348

MEG masked priming evidence for form-based decomposition of irregular verbs. Frontiers in Human Neuroscience 7: 798-798

MEG measures of covert orienting and gaze processing in children. Brain Topography 26(4): 616-626

MEG network differences between low- and high-grade glioma related to epilepsy and cognition. Plos One 7(11): E50122-E50122

MEG responses to the perception of global structure within glass patterns. Plos One 5(11): E13865-E13865

MEG resting state functional connectivity in Parkinson's disease related dementia. Journal of Neural Transmission 116(2): 193-202

MEG reveals a fast pathway from somatosensory cortex to occipital areas via posterior parietal cortex in a blind subject. Frontiers in Human Neuroscience 7: 429-429

MEG source imaging method using fast L1 minimum-norm and its applications to signals with brain noise and human resting-state source amplitude images. Neuroimage 84: 585-604

MEG source localization of spatially extended generators of epileptic activity: comparing entropic and hierarchical bayesian approaches. Plos One 8(2): E55969-E55969

MEG source localization using invariance of noise space. Plos One 8(3): E58408-E58408

MEG source reconstruction based on identification of directed source interactions on whole-brain anatomical networks. Neuroimage 105: 408-427

MEG spectral analysis in subtypes of mild cognitive impairment. Age 36(3): 9624-9624

MEG studies of motor cortex gamma oscillations: evidence for a gamma "fingerprint" in the brain?. Frontiers in Human Neuroscience 7: 575-575

MEG time-frequency analyses for pre- and post-surgical evaluation of patients with epileptic rhythmic fast activity. Epilepsy Research 88(2-3): 100-107

MEG's ability to localise accurately weak transient neural sources. Clinical Neurophysiology 120(11): 1958-1970

MEG-EEG fusion by Kalman filtering within a source analysis framework. Conference Proceedings 2013: 4819-4822

MEG-SIM: a web portal for testing MEG analysis methods using realistic simulated and empirical data. Neuroinformatics 10(2): 141-158

MEG-based decoding of the spatiotemporal dynamics of visual category perception. Neuroimage 83: 1063-1073

MEG-fMRI integration to visualize brain dynamics while perceiving 3-D object shape from motion. Conference Proceedings 2011: 4917-4920

MEG/EEG source reconstruction, statistical evaluation, and visualization with NUTMEG. Computational Intelligence and Neuroscience 2011: 758973-758973

MEG3 imprinted gene contribution in tumorigenesis. International Journal of Cancer 129(4): 773-779

MEGA biocentric software for sequence and phylogenetic analysis: a review. International Journal of Bioinformatics Research and Applications 6(3): 230-240

MEGA spectrometer: a monochromator with supermillion resolution. Applied Optics 23(19): 3341-3341

MEGA ♪ --Empirical Support for Nomenclature on the Anomalies: Sexually Violent and Predatory Youth. International Journal of Offender Therapy and Comparative Criminology 59(11): 1222-1238

MEGA-CC: computing core of molecular evolutionary genetics analysis program for automated and iterative data analysis. Bioinformatics 28(20): 2685-2686

MEGA-MD: molecular evolutionary genetics analysis software with mutational diagnosis of amino acid variation. Bioinformatics 30(9): 1305-1307

MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Molecular Biology and Evolution 30(12): 2725-2729

MEGACELL: a nanocrystal model construction software for HRTEM multislice simulation. Ultramicroscopy 111(8): 1077-1082

MEGADOCK 3.0: a high-performance protein-protein interaction prediction software using hybrid parallel computing for petascale supercomputing environments. Source Code for Biology and Medicine 8(1): 18-18

MEGADOCK 4.0: an ultra-high-performance protein-protein docking software for heterogeneous supercomputers. Bioinformatics 30(22): 3281-3283

MEGADOCK: an all-to-all protein-protein interaction prediction system using tertiary structure data. Protein and Peptide Letters 21(8): 766-778

MEGANTE: a web-based system for integrated plant genome annotation. Plant & Cell Physiology 55(1): E2-E2

MEGAWHOP cloning: a method of creating random mutagenesis libraries via megaprimer PCR of whole plasmids. Methods in Enzymology 498: 399-406

MEGDEL Syndrome in a Child From Palestine: Report of a Novel Mutation in SERAC1 Gene. Journal of Child Neurology 30(8): 1053-1056

MEGF10 association with schizophrenia. Biological Psychiatry 63(5): 441-448

MEGF10 functions as a receptor for the uptake of amyloid-β. Febs Letters 584(18): 3936-3942

MEGF8 is a modifier of BMP signaling in trigeminal sensory neurons. Elife 2: E01160-E01160

MEGU: pathway mapping web-service based on KEGG and SVG. In Silico Biology 6(6): 621-625

MEGen: A Physiologically Based Pharmacokinetic Model Generator. Frontiers in Pharmacology 2: 56-56

MEH-PPV by microwave assisted ring-opening metathesis polymerisation. Chemical Communications: 2676-2678

MEIG1 is essential for spermiogenesis in mice. Proceedings of the National Academy of Sciences of the United States of America 106(40): 17055-17060

MEIGO: an open-source software suite based on metaheuristics for global optimization in systems biology and bioinformatics. Bmc Bioinformatics 15(): 136-136

MEIMAN: Database exploring Medicinal and Edible insects of Manipur. Bioinformation 8(10): 489-491

MEIOB targets single-strand DNA and is necessary for meiotic recombination. Plos Genetics 9(9): E1003784-E1003784

MEIS proteins as partners of the TLX1/HOX11 oncoprotein. Leukemia Research 34(3): 358-363

MEIS1 functions as a potential AR negative regulator. Experimental Cell Research 328(1): 58-68

MEIS1 p.R272H in familial restless legs syndrome. Neurology 73(3): 243-245

MEIS1 regulates early erythroid and megakaryocytic cell fate. Haematologica 99(10): 1555-1564

MEK and EGFR inhibition demonstrate synergistic activity in EGFR-dependent NSCLC. Cancer Biology & Therapy 8(6): 522-530

MEK and MAF in myeloma therapy. Blood 117(8): 2300-2302

MEK in cancer and cancer therapy. Pharmacology & Therapeutics 141(2): 160-171

MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors. Journal of Clinical Investigation 123(1): 340-347

MEK inhibition in BRAF-mutated melanoma. New England Journal of Medicine 367(14): 1364-1365

MEK inhibition in non-small cell lung cancer. Lung Cancer 86(2): 121-125

MEK inhibition in the treatment of advanced melanoma. Current Oncology Reports 15(5): 473-482

MEK inhibition increases lapatinib sensitivity via modulation of FOXM1. Current Medicinal Chemistry 20(19): 2486-2499

MEK inhibition induces caspases activation, differentiation blockade and PML/RARalpha degradation in acute promyelocytic leukaemia. British Journal of Haematology 142(1): 27-35

MEK inhibition leads to PI3K/AKT activation by relieving a negative feedback on ERBB receptors. Cancer Research 72(13): 3228-3237

MEK inhibition potentiates the activity of Hsp90 inhibitor 17-AAG against pancreatic cancer cells. Molecular Pharmaceutics 7(5): 1576-1584

MEK inhibition prevents tumour-shed transforming growth factor-β-induced T-regulatory cell augmentation in tumour milieu. Immunology 144(4): 561-573

MEK inhibition reduces glial scar formation and promotes the recovery of sensorimotor function in rats following spinal cord injury. Experimental and Therapeutic Medicine 7(1): 66-72

MEK inhibition suppresses cell invasion and migration in ovarian cancers with activation of ERK1/2. Experimental and Therapeutic Medicine 1(4): 591-596

MEK inhibition, alone or in combination with BRAF inhibition, affects multiple functions of isolated normal human lymphocytes and dendritic cells. Cancer Immunology Research 2(4): 351-360

MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo. Molecular Cancer Therapeutics 9(7): 1968-1976

MEK inhibitor U0126 reverses protection of axons from Wallerian degeneration independently of MEK-ERK signaling. Plos One 8(10): E76505-E76505

MEK inhibitor effective against proliferation in breast cancer cell. Tumour Biology 35(9): 9269-9279

MEK inhibitor for gastric cancer with MEK1 gene mutations. Molecular Cancer Therapeutics 13(12): 3098-3106

MEK inhibitors suppress beta-amyloid production by altering the level of a beta-C-terminal fragment of amyloid precursor protein in neuronal cells. Febs Letters 584(15): 3410-3414

MEK inhibitors suppressed expression of NOS in spinal cord of morphine-induced dependent and withdrawal rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi 27(3): 343-347

MEK inhibitors, novel anti-adhesive molecules, reduce sickle red blood cell adhesion in vitro and in vivo, and vasoocclusion in vivo. Plos One 9(10): E110306-E110306

MEK inhibitors: a patent review 2008 - 2010. Expert Opinion on Therapeutic Patents 21(7): 1045-1069

MEK kinase 1: kinase domain deficiency in mice reveals a role in orchestrating the thymus-dependent immunity and TNFR family signaling. Advances in Experimental Medicine and Biology 691: 391-397

MEK mediates the novel cross talk between TNFR2 and TGF-EGFR in enhancing vascular endothelial growth factor (VEGF) secretion from human mesenchymal stem cells. Surgery 146(2): 198-205

MEK modulates force-fluctuation-induced relengthening of canine tracheal smooth muscle. European Respiratory Journal 36(3): 630-637

MEK signaling is required for phosphorylation of eIF2alpha following amino acid limitation of HepG2 human hepatoma cells. Journal of Biological Chemistry 283(16): 10848-10857

MEK targeting in N-RAS mutated metastatic melanoma. Molecular Cancer 13(): 45-45

MEK, p38, and PI-3K mediate cross talk between EGFR and TNFR in enhancing hepatocyte growth factor production from human mesenchymal stem cells. American Journal of Physiology. Cell Physiology 297(5): C1284-C1293

MEK-ERK and heparin-susceptible signaling pathways are involved in cell-cycle entry of the wound edge retinal pigment epithelium cells in the adult newt. Pigment Cell & Melanoma Research 25(1): 66-82

MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation. Journal of Clinical Investigation 121(3): 1009-1025

MEK-ERK1/2-dependent FLNA overexpression promotes abnormal dendritic patterning in tuberous sclerosis independent of mTOR. Neuron 84(1): 78-91

MEK-dependent negative feedback underlies BCR-ABL-mediated oncogene addiction. Cancer Discovery 4(2): 200-215

MEK-independent survival of B-RAFV600E melanoma cells selected for resistance to apoptosis induced by the RAF inhibitor PLX4720. Clinical Cancer Research 17(4): 721-730

MEK/ERK activation plays a decisive role in yellow fever virus replication: implication as an antiviral therapeutic target. Antiviral Research 111: 82-92

MEK/ERK and p38 MAPK regulate chondrogenesis of rat bone marrow mesenchymal stem cells through delicate interaction with TGF-beta1/Smads pathway. Cell Proliferation 43(4): 333-343

MEK/ERK dependent activation of STAT1 mediates dasatinib-induced differentiation of acute myeloid leukemia. Plos One 8(6): E66915-E66915

MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma. Molecular Cancer Therapeutics 8(3): 543-551

MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals. Molecular Cancer Therapeutics 10(1): 159-168

MEK/ERK pathway inhibitors as a treatment for inflammatory arthritis might result in the development of lupus: comment on the article by Thiel et al. Arthritis and Rheumatism 58(4): 1203-4; Author Reply 1204

MEK/ERK pathway mediates UVB-induced AQP1 downregulation and water permeability impairment in human retinal pigment epithelial cells. International Journal of Molecular Medicine 23(6): 771-777

MEK/ERK pathway mediates cytoprotection of salvianolic acid B against oxidative stress-induced apoptosis in rat bone marrow stem cells. Cell Biology International 34(11): 1063-1068

MEK/ERK signaling directly and indirectly contributes to the cyclical self-renewal of spermatogonial stem cells. Stem Cells 31(11): 2517-2527

MEK/ERK-mediated phosphorylation of Bim is required to ensure survival of T and B lymphocytes during mitogenic stimulation. Journal of Immunology 183(1): 261-269

MEK/ERKs signaling is essential for lithium-induced neurite outgrowth in N2a cells. International Journal of Developmental Neuroscience 29(4): 415-422

MEK/Erk-based negative feedback mechanism involved in control of Steel Factor-triggered production of Krüppel-like factor 2 in mast cells. Cellular Signalling 24(4): 879-888

MEK/MAPK inhibitors. Journal of Thoracic Oncology 5(12 Suppl 6): S474-S475

MEK1 and AKT2 mutations in Japanese lung cancer. Journal of Thoracic Oncology 5(5): 597-600

MEK1 and MEK2 differentially control the duration and amplitude of the ERK cascade response. Physical Biology 10(3): 035006-035006

MEK1 and MEK2 differentially regulate human insulin- and insulin glargine-induced human bladder cancer T24 cell proliferation. Chinese Medical Journal 125(23): 4197-4201

MEK1 and MEK2 isoforms regulate distinct functions in pancreatic cancer cells. Oncology Reports 24(1): 251-255

MEK1 binds directly to betaarrestin1, influencing both its phosphorylation by ERK and the timing of its isoprenaline-stimulated internalization. Journal of Biological Chemistry 284(17): 11425-11435

MEK1 gene mutation in Japanese lung adenocarcinoma patients. Molecular Medicine Reports 2(2): 153-155

MEK1 inhibits cardiac PPARα activity by direct interaction and prevents its nuclear localization. Plos One 7(6): E36799-E36799

MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer. Bmc Cancer 14(): 837-837

MEK1 mutations confer resistance to MEK and B-RAF inhibition. Proceedings of the National Academy of Sciences of the United States of America 106(48): 20411-6

MEK1 mutations, but not ERK2 mutations, occur in melanomas and colon carcinomas, but none in thyroid carcinomas. Cell Cycle 8(13): 2122-2124

MEK1 plays contrary stage-specific roles in skeletal myogenic differentiation. Cellular Signalling 21(12): 1910-1917

MEK1 promotes YAP and their interaction is critical for tumorigenesis in liver cancer. Febs Letters 587(24): 3921-3927

MEK1 transduces the prion protein N2 fragment antioxidant effects. Cellular and Molecular Life Sciences 72(8): 1613-1629

MEK1/2 and p38-like MAP kinase successively mediate H(2)O(2) signaling in Vicia guard cell. Plant Signaling & Behavior 3(11): 996-998

MEK1/2 induces STAT5-mediated germline transcription of the TCRgamma locus in response to IL-7R signaling. Journal of Immunology 181(1): 494-502

MEK1/2 inhibition decreases lactate in BRAF-driven human cancer cells. Cancer Research 73(13): 4039-4049

MEK1/2 inhibition delays progression of uveal melanoma. Lancet. Oncology 15(9): E366-E366

MEK1/2 inhibition elicits regression of autochthonous lung tumors induced by KRASG12D or BRAFV600E. Cancer Research 72(12): 3048-3059

MEK1/2 inhibition enhances the radiosensitivity of cancer cells by downregulating survival and growth signals mediated by EGFR ligands. International Journal of Oncology 42(6): 2028-2036

MEK1/2 inhibition suppresses tamoxifen toxicity on CNS glial progenitor cells. Journal of Neuroscience 33(38): 15069-15074

MEK1/2 inhibitors AS703026 and AZD6244 may be potential therapies for KRAS mutated colorectal cancer that is resistant to EGFR monoclonal antibody therapy. Cancer Research 71(2): 445-453

MEK1/2 inhibitors block basal and transforming growth factor 1beta1-stimulated JC virus multiplication. Journal of Virology 81(12): 6412-6418

MEK1/2 inhibitors in the treatment of gynecologic malignancies. Gynecologic Oncology 133(1): 128-137

MEK1/2 is a critical regulator of microtubule assembly and spindle organization during rat oocyte meiotic maturation. Molecular Reproduction and Development 75(10): 1542-1548

MEK1/2 overactivation can promote growth arrest by mediating ERK1/2-dependent phosphorylation of p70S6K. Journal of Cellular Physiology 229(7): 903-915

MEK2 is sufficient but not necessary for proliferation and anchorage-independent growth of SK-MEL-28 melanoma cells. Plos One 6(2): E17165-E17165

MEK2 regulates ribonucleotide reductase activity through functional interaction with ribonucleotide reductase small subunit p53R2. Cell Cycle 11(17): 3237-3249

MEK4 function, genistein treatment, and invasion of human prostate cancer cells. Journal of the National Cancer Institute 101(16): 1141-1155

MEK5 and ERK5 are mediators of the pro-myogenic actions of IGF-2. Journal of Cell Science 122(Pt 17): 3104-3112

MEK5 is activated by shear stress, activates ERK5 and induces KLF4 to modulate TNF responses in human dermal microvascular endothelial cells. Microcirculation 18(2): 102-117

MEK5/ERK5 signaling modulates endothelial cell migration and focal contact turnover. Journal of Biological Chemistry 284(37): 24972-24980

MEK5/ERK5 signaling suppresses estrogen receptor expression and promotes hormone-independent tumorigenesis. Plos One 8(8): E69291-E69291

MEK5/ERK5/mef2: a novel signaling pathway affected by hepatitis C virus non-enveloped capsid-like particles. Biochimica et Biophysica Acta 1813(10): 1854-1862

MEKC as a powerful growing analytical technique. Electrophoresis 32(1): 166-183

MEKC determination of IgG in human serum via a pH-mediated acid stacking method. Journal of Separation Science 33(19): 3068-3074

MEKC determination of vanadium from mineral ore and crude petroleum oil samples using precapillary chelation with bis(salicylaldehyde)tetramethyl-ethylenediimine. Journal of Separation Science 32(18): 3169-3177

MEKC-DAD fingerprint of Radix et Rhizoma Rhei. Zhongguo Zhong Yao Za Zhi 34(23): 3034-3038

MEKC-LIF analysis of rhodamine123 delivered by carbon nanotubes in K562 cells. Electrophoresis 30(11): 1906-1912

MEKC-MS/MS method using a volatile surfactant for the simultaneous determination of 12 synthetic cannabinoids. Journal of Separation Science 37(3): 304-307

MEKC: a powerful tool for the determination of amino acids in a variety of biomatrices. Electrophoresis 31(1): 93-104

MEKK1 binds HECT E3 ligase Itch by its amino-terminal RING motif to regulate Th2 cytokine gene expression. Journal of Immunology 183(6): 3831-3838

MEKK1-MKK4-JNK-AP1 pathway negatively regulates Rgs4 expression in colonic smooth muscle cells. Plos One 7(4): E35646-E35646

MEKK1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylation. Oncology Reports 25(2): 537-544

MEKK2 kinase association with 14-3-3 protein regulates activation of c-Jun N-terminal kinase. Journal of Biological Chemistry 288(39): 28293-28302

MEKK2 regulates focal adhesion stability and motility in invasive breast cancer cells. Biochimica et Biophysica Acta 1843(5): 945-954

MEKK2 regulates paxillin ubiquitylation and localization in MDA-MB 231 breast cancer cells. Biochemical Journal 464(1): 99-108

MEKK3 and TAK1 synergize to activate IKK complex in Helicobacter pylori infection. Biochimica et Biophysica Acta 1843(4): 715-724

MEKK3 and survivin expression in cervical cancer: association with clinicopathological factors and prognosis. Asian Pacific Journal of Cancer Prevention 15(13): 5271-5276

MEKK3 expression correlates with nuclear factor kappa B activity and with expression of antiapoptotic genes in serous ovarian carcinoma. Cancer 115(17): 3897-3908

MEKK3 initiates transforming growth factor beta 2-dependent epithelial-to-mesenchymal transition during endocardial cushion morphogenesis. Circulation Research 103(12): 1430-1440

MEKK3 is essential for lymphopenia-induced T cell proliferation and survival. Journal of Immunology 182(6): 3597-3608

MEKK3 is required for lysophosphatidic acid-induced NF-kappaB activation. Cellular Signalling 21(10): 1488-1494

MEKK3 overexpression contributes to the hyperresponsiveness of IL-12-overproducing cells and CD4+ T conventional cells in nonobese diabetic mice. Journal of Immunology 185(6): 3554-3563

MEKK4 sequesters RIP2 to dictate NOD2 signal specificity. Current Biology 18(18): 1402-1408

MEKK4 stimulation of p38 and JNK activity is negatively regulated by GSK3beta. Journal of Biological Chemistry 282(42): 30476-30484

MEKing it easier to prevent GVHD. Blood 121(23): 4611-4612

MELAS and L-arginine therapy: pathophysiology of stroke-like episodes. Annals of the New York Academy of Sciences 1201: 104-110

MELAS and reversible vasoconstriction of the major cerebral arteries. Internal Medicine 52(12): 1389-1392

MELAS as a cause of stroke in the elderly. Revue Neurologique 165(11): 990-992

MELAS associated pathological hyperemotionalism: a case report. Annals of the Academy of Medicine, Singapore 40(9): 418-419

MELAS in the heart. International Journal of Cardiology 137(3): E65-E66

MELAS masquerading as a systemic vasculitis. Journal of Clinical Rheumatology 13(6): 334-337

MELAS phenotype associated with m.3302A>G mutation in mitochondrial tRNA(Leu(UUR)) gene. Brain & Development 36(2): 180-182

MELAS presented with status epilepticus and Anton-Babinski syndrome; value of ADC mapping in MELAS. Journal of Neuropsychiatry and Clinical Neurosciences 19(4): 482-483

MELAS syndrome as a differential diagnosis of ischemic stroke. Fortschritte der Neurologie-Psychiatrie 77(1): 25-31

MELAS syndrome associated with both A3243G-tRNALeu mutation and multiple mitochondrial DNA deletions. Journal of the Neurological Sciences 296(1-2): 101-103

MELAS syndrome diagnosed in ICU in a 56-year-old patient presenting with status epilepticus. Intensive Care Medicine 39(6): 1148-1149

MELAS syndrome in an Indigenous Australian woman. Medical Journal of Australia 195(10): 581-582

MELAS syndrome presenting as an acute surgical abdomen. Annals of the Royal College of Surgeons of England 96(1): 101e-103e

MELAS syndrome, cardiomyopathy, rhabdomyolysis, and autism associated with the A3260G mitochondrial DNA mutation. Biochemical and Biophysical Research Communications 402(2): 443-447

MELAS syndrome, diabetes and thyroid disease: the role of mitochondrial oxidative stress. Clinical Endocrinology 70(2): 340-341

MELAS with A3243G mutation presenting with occipital status epilepticus. Journal of Child Neurology 24(12): 1564-1567

MELAS with diffuse degeneration of the cerebral white matter: report of an autopsy case. Neuropathology 30(1): 56-60

MELAS with recurrent complex partial seizures, nonconvulsive status epilepticus, psychosis, and behavioral disturbances: case analysis with literature review. Epilepsy & Behavior 18(4): 494-497

MELAS, an important consideration in the adult population presenting with unusual and recurrent stroke-like episodes. Bmj Case Reports 2014: -

MELAS/SANDO overlap syndrome associated with POLG1 mutations. Neurological Sciences 33(1): 209-212

MELAS: A Multigenerational Impact of the MTTL1 A3243G MELAS Mutation. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 41(2): 210-219

MELAS: a mitochondrial disorder in an adult patient with a renal transplant. Wiener Klinische Wochenschrift 122(11-12): 363-365

MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochimica et Biophysica Acta 1820(5): 619-624

MELAS: clinical features, muscle biopsy and molecular genetics. Arquivos de Neuro-Psiquiatria 67(3a): 668-676

MELAS: diagnostic keys and treatment in the Intensive Care Unit. Medicina Intensiva 32(3): 147-150

MELAS: recurrent reversible hemianopia. Neurology India 58(5): 791-793

MELD and gender in the waiting list for liver transplantation. Transplantation 85(10): 1509-10; Author Reply 1510

MELD and other predictors of survival after liver transplantation. Clinical Transplantation 23(2): 220-227

MELD at POD 1 as a predictor of outcome in liver allografts with peak AST >5000 U/l. Transplant International 27(12): 1285-1293

MELD era: is this time to replace the original Child-Pugh score in patients with decompensated cirrhosis of liver. Journal of the College of Physicians and Surgeons--Pakistan 20(7): 432-435

MELD exception for liver transplantation in portopulmonary hypertension: current implementation and future considerations. Annals of Hepatology 13(6): 719-721

MELD exceptions and new predictive score of death on long waiting lists for liver transplantation. Chirurgia 104(3): 267-273

MELD exceptions for portopulmonary hypertension: current policy and future implementation. American Journal of Transplantation 14(9): 2081-2087

MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transplantation 13(6): 822-828

MELD or Maddrey?: comparison of two prognosis models in patients with alcohol toxic hepatitis. Revista de Gastroenterologia de Mexico 73(2): 57-62

MELD predicts mortality in conservatively managed pneumatosis intestinalis in cirrhotics. International Journal of Surgery 11(9): 816-818

MELD score and albumin replacement are related to higher costs during management of patients with refractory ascites. Transplantation Proceedings 46(6): 1760-1763

MELD score and antibiotics use are predictors of length of stay in patients hospitalized with hepatic encephalopathy. Bmc Gastroenterology 14(): 185-185

MELD score and blood product requirements during liver transplantation: no link. Transplantation 87(11): 1689-1694

MELD score can predict early mortality in patients with rebleeding after band ligation for variceal bleeding. World Journal of Gastroenterology 17(16): 2120-2125

MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology 138(1): 159-164

MELD score less than 15 predicts prolonged survival after transjugular intrahepatic portosystemic shunt for refractory ascites after liver transplantation. Transplantation 91(7): 786-792

MELD score, child-pugh score, and decreased albumin as risk factors for gastric variceal bleeding. Hepato-Gastroenterology 56(94-95): 1552-1556

MELD score, insulin-like growth factor 1 and cytokines on bone density in end-stage liver disease. World Journal of Hepatology 3(6): 157-163

MELD score, step forward to justice of liver graft allocation in Brazil. Arquivos de Gastroenterologia 44(3): 187-188

MELD score: utility and comparison with King's College criteria in non-acetaminophen acute liver failure. Journal of the College of Physicians and Surgeons--Pakistan 22(8): 492-496

MELD--an imperfect, but thus far the best, solution to the problem of organ allocation. Journal of Gastrointestinal and Liver Diseases 17(1): 5-7

MELD-Na as a prognostic score for cirrhotic patients: Hyponatremia and ascites are back in the game. Journal of Hepatology 50(4): 836-838

MELD-Na: effective in predicting rebleeding in cirrhosis after cessation of esophageal variceal hemorrhage by endoscopic therapy. Journal of Clinical Gastroenterology 48(10): 870-877

MELD-sodium score and its prognostic value in malignancy-related ascites of pancreatic and gastric cancer. Supportive Care in Cancer 21(4): 1153-1156

MELDolody: the science of liver allocation. American Journal of Transplantation 8(9): 1763-1764

MELF invasion in endometrial cancer as a risk factor for lymph node metastasis. Histopathology 58(6): 966-973

MELF pattern invasion in endometrial carcinoma: association with low grade, myoinvasive endometrioid tumours, focal mucinous differentiation and vascular invasion. Pathology 41(5): 454-459

MELISA-an in vitro tool for the study of metal allergy. Toxicology in Vitro 8(5): 991-1000

MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs. Thrombosis and Haemostasis 110(4): 844-851

MELK inhibitor, novel molecular targeted therapeutics for human cancer stem cells. Cell Cycle 12(11): 1655-1656

MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells. Elife 3: E01763-E01763

MELODI: the 'Multidisciplinary European Low-Dose Initiative'. Radiation Protection Dosimetry 143(2-4): 330-334

MELODIE: a whole-farm model to study the dynamics of nutrients in dairy and pig farms with crops. Animal 6(10): 1711-1721

MELOE-1 antigen contains multiple HLA class II T cell epitopes recognized by Th1 CD4+ T cells from melanoma patients. Plos One 7(12): E51716-E51716

MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency. Journal of Experimental Medicine 205(11): 2673-2682

MELT Japan (MCA-Embolism Local Fibrinolytic Intervention Trial Japan). Nihon Rinsho. Japanese Journal of Clinical Medicine 64 Suppl 7: 519-523

MELTING, a flexible platform to predict the melting temperatures of nucleic acids. Bmc Bioinformatics 13(): 101-101

MEM's search for meaning: a rejoinder. PsychoTherapy Research 20(1): 93-99

MEM: Mechanisms of Recollection. Journal of Cognitive Neuroscience 4(3): 268-280

MEMBPLUGIN: studying membrane complexity in VMD. Bioinformatics 30(10): 1478-1480

MEME SUITE: tools for motif discovery and searching. Nucleic Acids Research 37(Web Server Issue): W202-W208

MEME-ChIP: motif analysis of large DNA datasets. Bioinformatics 27(12): 1696-1697

MEMENTA-'Mental healthcare provision for adults with intellectual disability and a mental disorder'. A cross-sectional epidemiological multisite study assessing prevalence of psychiatric symptomatology, needs for care and quality of healthcare provision for adults with intellectual disability in Germany: a study protocol. Bmj Open 4(5): E004878-E004878

MEMO associated with an ErbB2 receptor phosphopeptide reveals a new phosphotyrosine motif. Febs Letters 585(17): 2688-2692

MEMO--a mobile phone depression prevention intervention for adolescents: development process and postprogram findings on acceptability from a randomized controlled trial. Journal of Medical Internet Research 14(1): E13-E13

MEMOIR: Frederick Shepard Dennis 1850-1934. Annals of Surgery 101(5): 1297-1298

MEMOPS: data modelling and automatic code generation. Journal of Integrative Bioinformatics 7(3): -

MEMORANDUM ON THE TREATMENT OF INFECTED WOUNDS BY PHYSIOLOGICAL METHODS: (Drainage of Infected Tissues by Hypertonic Salt Solution, and Utilization of the Antibacterial Powers of the Blood Fluids and White Blood Corpuscles.). British Medical Journal 1(2892): 793-797

MEMORANDUM on epidemiological reporting. Bulletin of Communicable Diseases and Medical Notes. United Nations Relief and Rehabilitation Administration 5(10): 1507-1523

MEMORANDUM on the International Penicillin Standard and the International Penicillin Working Standard. Bulletin. Health Organisation 12(2): 243-249

MEMORANDUM on the teaching of tuberculosis to medical students. Medical World 63: 661-661

MEMORANDUM on yellow fever in British Guiana. Annual Report. British Guiana. Mosquito Control Service: 6-6

MEMORANDUM presented by the Bengal Public Health Association to the Health Survey and Development Committee of the Government of India on the public administration of the Province. Bengal Public Health Journal 3: 165-196

MEMORANDUM: Regarding a Family in which Neuro-Retinal Disease of an unusual kind occurred only in the Males. British Journal of Ophthalmology 16(12): 681-686

MEMORIAL ADDRESSES: Hideyo Noguchi. Bulletin of the New York Academy of Medicine 5(9): 877-886

MEMOSys 2.0: an update of the bioinformatics database for genome-scale models and genomic data. Database 2014: Bau004-Bau004

MEMOSys: Bioinformatics platform for genome-scale metabolic models. Bmc Systems Biology 5(): 20-20

MEMRO 2009--middle-ear science and technology. Hearing Research 263(1-2): 1-2

MEMS Biomimetic Acoustic Pressure Gradient Sensitive Structure for Sound Source Localization. Sensors 9(7): 5637-5648

MEMS Bragg grating force sensor. Optics Express 19(20): 19190-8

MEMS Electrostatic Actuation in Conducting Biological Media. Journal of Microelectromechanical Systems 18(2): 405-413

MEMS Fabry-Perot sensor interrogated by optical system-on-a-chip for simultaneous pressure and temperature sensing. Optics Express 21(19): 21829-21839

MEMS Sensors and Microsystems for Cell Mechanobiology. Journal of Micromechanics and Microengineering 21(5): 54002-54012

MEMS accelerometer embedded in a self-mixing displacement sensor for parasitic vibration compensation. Optics Letters 36(5): 612-614

MEMS and microfluidics for diagnostics devices. Current Pharmaceutical Biotechnology 11(4): 366-375

MEMS and the microbe. Lab on A Chip 8(10): 1604-1616

MEMS based Low Cost Piezoresistive Microcantilever Force Sensor and Sensor Module. Materials Science in Semiconductor Processing 19: 163-173

MEMS based hair flow-sensors as model systems for acoustic perception studies. Nanotechnology 17(4): S84-S89

MEMS biosensor for detection of Hepatitis A and C viruses in serum. Biosensors & Bioelectronics 28(1): 189-194

MEMS biosensors for detection of methicillin resistant Staphylococcus aureus. Biosensors & Bioelectronics 29(1): 1-12

MEMS capacitive accelerometer-based middle ear microphone. IEEE Transactions on Bio-Medical Engineering 59(12): 3283-3292

MEMS capacitive force sensors for cellular and flight biomechanics. Biomedical Materials 2(1): S16-S22

MEMS compatible micro-GRIN lenses for fiber to chip coupling of light. Optics Express 14(10): 4237-4249

MEMS fabricated chip for an implantable drug delivery device. Conference Proceedings 1: 5621-5624

MEMS fluid viscosity sensor. IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control 57(3): 669-676

MEMS for enhanced optical diagnostics in endoscopy. Minimally Invasive Therapy & Allied Technologies 16(2): 101-108

MEMS micromirror characterization in space environments. Optics Express 17(5): 3370-3380

MEMS microwell and microcolumn arrays: novel methods for high-throughput cell-based assays. Lab on A Chip 11(21): 3619-3625

MEMS reconfigurable metamaterial for terahertz switchable filter and modulator. Optics Express 22(18): 21326-21339

MEMS scanner enabled real-time depth sensitive hyperspectral imaging of biological tissue. Optics Express 18(23): 24101-8

MEMS segmented-based adaptive optics scanning laser ophthalmoscope. Biomedical Optics Express 2(5): 1204-1217

MEMS thermal sensors to detect changes in heat transfer in the pre-atherosclerotic regions of fat-fed New Zealand white rabbits. Annals of Biomedical Engineering 39(6): 1736-1744

MEMS within a Swagelok: a new platform for microfluidic devices. Lab on A Chip 9(13): 1966-1969

MEMS-Based Dual Axes Confocal Microendoscopy. IEEE Journal of Selected Topics in Quantum Electronics 16(4): 804-814

MEMS-assisted spatially homogeneous endothelialization of a high length-to-depth aspect ratio microvascular network. Conference Proceedings 2011: 290-293

MEMS-based 3D optical microendoscopy. Conference Proceedings 2009: 6703-6705

MEMS-based bubble pressure sensor for prosthetic socket interface pressure measurement. Conference Proceedings 2011: 2925-2928

MEMS-based fabrication and microfluidic analysis of three-dimensional perfusion systems. Biomedical Microdevices 10(3): 437-446

MEMS-based fast scanning probe microscopes. Ultramicroscopy 110(6): 599-604

MEMS-based force-clamp analysis of the role of body stiffness in C. elegans touch sensation. Integrative Biology 5(6): 853-864

MEMS-based handheld confocal microscope for in-vivo skin imaging. Optics Express 18(4): 3805-3819

MEMS-based high speed scanning probe microscopy. Review of Scientific Instruments 81(4): 043702-043702

MEMS-based optical beam steering system for quantum information processing in two-dimensional atomic systems. Optics Letters 33(3): 273-275

MEMS-based optical limiter. Applied Optics 47(29): 5468-5472

MEMS-based power generation techniques for implantable biosensing applications. Sensors 11(2): 1433-1460

MEMS-based probe recording technology. Journal of Nanoscience and Nanotechnology 7(1): 181-192

MEMS-based shear characterization of soft hydrated samples. Journal of Micromechanics and Microengineering 23(8): -

MEMS-based tunable terahertz wire-laser over 330 GHz. Optics Letters 36(5): 692-694

MEMS-enabled implantable drug infusion pumps for laboratory animal research, preclinical, and clinical applications. Advanced Drug Delivery Reviews 64(14): 1628-1638

MEMSurgery: an integrated test-bed for vascular surgery. International Journal of Medical Robotics + Computer Assisted Surgery 1(3): 21-30

MEN 2 syndrome masquerading as MEN 1. Annals of the Royal College of Surgeons of England 94(6): E206-E207

MEN 2A family--prophylactic thyroidectomy for asymptomatic siblings with positive 634 codon mutation. Journal of the Association of Physicians of India 60: 127-129

MEN 2B syndrome should be part of the working diagnosis of constipation of the newborn. Histopathology 52(5): 646-648

MEN epsilon/beta nuclear-retained non-coding RNAs are up-regulated upon muscle differentiation and are essential components of paraspeckles. Genome Research 19(3): 347-359

MEN syndromes. Tumori 96(5): 823-826

MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations. Best Practice & Research. Clinical Endocrinology & Metabolism 24(3): 425-437

MEN1 935-1G>C splicing mutation in an Indian patient with multiple endocrine neoplasia type 1. Molecular Diagnosis & Therapy 11(2): 129-131

MEN1 Syndrome and Hibernoma: An Uncommonly Recognised Association?. Case Reports in Medicine 2014: 804580-804580

MEN1 and pituitary adenomas. Annales D'endocrinologie 73(2): 59-61

MEN1 clinical background. Advances in Experimental Medicine and Biology 668: 1-15

MEN1 gastrinoma: routine duodenal exploration!. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 83(5): 480-481

MEN1 gene analysis in patients with primary hyperparathyroidism: 10-year experience of a single institution for thyroid and parathyroid care in Japan. Endocrine Journal 56(5): 649-656

MEN1 gene and its mutations: basic and clinical implications. Cancer Science 100(2): 209-215

MEN1 gene mutation and reduced expression are associated with poor prognosis in pulmonary carcinoids. Journal of Clinical Endocrinology and Metabolism 99(2): E374-E378

MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1. Clinical Endocrinology 67(5): 727-734

MEN1 gene replacement therapy reduces proliferation rates in a mouse model of pituitary adenomas. Cancer Research 72(19): 5060-5068

MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases. Endocrine-Related Cancer 17(3): 771-783

MEN1 missense mutations impair sensitization to apoptosis induced by wild-type menin in endocrine pancreatic tumor cells. Gastroenterology 135(5): 1698-1709.E2

MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly. European Journal of Endocrinology 167(2): 157-164

MEN16132, a kinin B2 receptor antagonist, prevents the endogenous bradykinin effects in guinea-pig airways. European Journal of Pharmacology 579(1-3): 350-356

MEN2B syndrome presenting as an acute respiratory emergency. Bmj Case Reports 2013: -

MENA is a transcriptional target of the Wnt/beta-catenin pathway. Plos One 7(5): E37013-E37013

MENACE of indiscriminate transportation of animals by air. Veterinary Record 59(13): 185-185

MENHOB - Mental Health on Board 12th International Symposium on Maritime Health Brest, France, June 6, 2013. International Maritime Health 64(3): 168-174

MENNINGER Foundation School of Psychiatry. Bulletin of the Menninger Clinic 10: 1-9

MENOPOST--calcium and vitamin D supplementation in postmenopausal osteoporosis treatment: a descriptive cohort study. Osteoporosis International 24(2): 559-566

MENT: methylation and expression database of normal and tumor tissues. Gene 518(1): 194-200

MENTAL CONSEQUENCES OF TORTURE: The Method of Rehabilitation at a Rehabilitation Centre at Copenhagen. Indian Journal of Psychiatry 28(3): 225-229

MENTAL PECULIARITIES in HAEMOPHILIA. British Medical Journal 1(1947): 1066-1066

MENTAL SYMPTOMS IN PHYSICAL DISEASE: Being an Abridgement of the Bradshaw Lecture delivered before the Royal College of Physicians of London. British Medical Journal 2(3227): 841-844

MENTAL hospital services in the Union; an interview with the Minister of Health, Cape Town. South African Medical Journal 20: 390-390

MENTAL hygiene. Medical Officer 77(4): 36-36

MENTAL-HOSPITAL treatment of depression. Lancet 1(6547): 318-320

MENTHOL market. Drug and Cosmetic Industry 63(3): 314-314

MENTOR-VIP: Piloting a global mentoring program for injury and violence prevention. Academic Medicine 84(6): 793-796

MENTOR-VIP: helping develop key skills for injury and violence prevention. Injury Prevention 15(1): 68-68

MENX and MEN4. Clinics 67 Suppl 1: 13-18

MENepsilon/beta noncoding RNAs are essential for structural integrity of nuclear paraspeckles. Proceedings of the National Academy of Sciences of the United States of America 106(8): 2525-2530

MEOPA: analgesia in a bottle. Revue de L'infirmiere: 39-40

MEOX2 regulates nuclear factor-kappaB activity in vascular endothelial cells through interactions with p65 and IkappaBbeta. Cardiovascular Research 87(4): 723-731

MEP HyperCel chromatography II: binding, washing and elution. Protein Expression and Purification 71(2): 168-173

MEP and planetary climates: insights from a two-box climate model containing atmospheric dynamics. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 365(1545): 1355-1365

MEP calls for tougher legislation to stop drug trials that could be considered as marketing. Bmj 344: E4247-E4247

MEP pathway-mediated isopentenol production in metabolically engineered Escherichia coli. Microbial Cell Factories 13(): 135-135

MEP proposes tighter tests on potentially risky medical devices. Bmj 346: F2940-F2940

MEP showed peculiar changes after temporal ICA occlusion in aneurysm surgery, in spite of cerebral tolerance to preoperative test occlusion. A case report. No Shinkei Geka. Neurological Surgery 38(10): 939-944

MEPE activated by furin promotes pulpal cell adhesion. Journal of Dental Research 90(4): 529-534

MEPE evolution in mammals reveals regions and residues of prime functional importance. Cellular and Molecular Life Sciences 67(2): 305-320

MEPE's diverse effects on mineralization. Calcified Tissue International 86(1): 42-46

MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM. Journal of Bone and Mineral Research 23(10): 1638-1649

MEPE-derived ASARM peptide inhibits odontogenic differentiation of dental pulp stem cells and impairs mineralization in tooth models of X-linked hypophosphatemia. Plos One 8(2): E56749-E56749

MEPE/OF45 protects cells from DNA damage induced killing via stabilizing CHK1. Nucleic Acids Research 37(22): 7447-7454

MEPs approve funding for farm animal homeopathy pilot project. Veterinary Record 169(11): 274-274

MEPs back country of origin labelling for fresh meat. Veterinary Record 169(3): 61-61

MEPs back stronger controls on medical devices. Bmj 348: G2647-G2647

MEPs criticise WHO over H1N1 pandemic advice. Bmj 342: D652-D652

MEPs support professional qualifications e-card. Veterinary Record 172(5): 116-116

MER1, a novel organic arsenic derivative, has potent PML-RARalpha-independent cytotoxic activity against leukemia cells. Investigational New Drugs 28(4): 402-412

MER3 is required for normal meiotic crossover formation, but not for presynaptic alignment in rice. Journal of Cell Science 122(Pt 12): 2055-2063

MER41 repeat sequences contain inducible STAT1 binding sites. Plos One 5(7): E11425-E11425

MER5101, a novel Aβ1-15:DT conjugate vaccine, generates a robust anti-Aβ antibody response and attenuates Aβ pathology and cognitive deficits in APPswe/PS1ΔE9 transgenic mice. Journal of Neuroscience 33(16): 7027-7037

MER91B-assisted cryptic exon activation in Gitelman syndrome. Pediatric Research 67(4): 444; Author Reply 444-5

MERBROMIN solution. Bulletin. American Pharmaceutical Association. Committee on National Formulary 14: 20-20

MERCI Retriever. Clinical Privilege White Paper: 1-18

MERCI: a useful systematic 'aide memoir' to help clinicians teach ethics. Medical Education 43(12): 1218-1218

MERCURIAL antiseptics and estrogenic creams. American Professional Pharmacist 14(10): 917-917

MERE1, a low-copy-number copia-type retroelement in Medicago truncatula active during tissue culture. Plant Physiology 151(3): 1250-1263

MERGANSER: an empirical model to predict fish and loon mercury in New England lakes. Environmental Science & Technology 46(8): 4641-4648

MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks. Genes & Development 23(6): 740-754

MERIT40 facilitates BRCA1 localization and DNA damage repair. Genes & Development 23(6): 719-728

MERLIN Gets the Hubble Constant in Focus. Science 259(5094): 455-455

MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Research 42(Database Issue): D503-D509

MEROPS: the peptidase database. Nucleic Acids Research 36(Database Issue): D320-D325

MEROPS: the peptidase database. Nucleic Acids Research 38(Database Issue): D227-D233

MERRF and Kearns-Sayre overlap syndrome due to the mitochondrial DNA m.3291T>C mutation. Muscle & Nerve 44(3): 448-451

MERRF syndrome presenting with multiple symmetric lipomatosis in a Japanese patient. Internal Medicine 49(5): 479-482

MERRF-like phenotype associated with a rare mitochondrial trnaile mutation (m.4284 G>A). Neuropediatrics 42(4): 148-151

MERRF/MELAS overlap syndrome due to the m.3291T>C mutation. Metabolic Brain Disease 29(1): 139-144

MERRF/MELAS overlap syndrome: a double pathogenic mutation in mitochondrial tRNA genes. Journal of Medical Genetics 47(10): 659-664

MERRF: Clinical features, muscle biopsy and molecular genetics in Brazilian patients. Mitochondrion 11(3): 528-532

MERS coronavirus has low pandemic potential, so far. Bmj 347: F4371-F4371

MERS coronavirus in dromedary camel herd, Saudi Arabia. Emerging Infectious Diseases 20(7): 1231-1234

MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997. Emerging Infectious Diseases 20(12): 2093-2095

MERS coronavirus: data gaps for laboratory preparedness. Journal of Clinical Virology 59(1): 4-11

MERS coronaviruses in dromedary camels, Egypt. Emerging Infectious Diseases 20(6): 1049-1053

MERS coronovirus has probably been present in bats for many years, research shows. Bmj 347: F6141-F6141

MERS differs from SARS, say experts. Cmaj 186(9): E303-E304